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Chapter 1: Introduction 
 
1.1 BACKGROUND 
 
Health systems around the world are facing the twin pressures of increasing demand for services, 
caused largely by the impact of the ageing population and medical science developments, and a lack 
of resources consequent on economic slowdown in many countries (Lewis et al, 2010). In these 
circumstances, it should not be surprising that there is an increased focus on the issue of variation in 
the provision, uptake and costs of health care (Corallo et al, 2013) a focus that anticipates health 
systems to act to identify and reduce unwarranted variation. Put simply, this means exploring 
differences in the cost or the way care is organised and provided from one area to another for the 
same condition or diagnosis, or a difference in the access to care for the same or similar conditions. 
This is neatly described by Sipkoff (2003) who claimed: 
 
“When the approach in one town is major surgery and in another, it’s watchful waiting, you 
know there’s a problem.” 
 
The concept of variation follows two distinct classifications. It is frequently described as being either 
“warranted” or “unwarranted” and it is difficult, but necessary, to attempt to distinguish between 
the two. Warranted variation is described as those differences that reflect patient centred care and 
clinical responsiveness, founded on the basis of assessed need for a population served (Department 
of Health [DH], 2010c). It needs to be considered separately from unwarranted variation, which is 
defined as “variation in the utilisation of health care services that cannot be explained by variation in 
patient illness or patient preferences” (Wennberg, 2010) and is considered unacceptable as it not 
only wastes valuable resources but is the hallmark of poor quality of health care (Hannan, 1999).  
 
The conundrum that unwarranted variation poses remains practically and politically ambiguous, as 
both a concept and in solution (Bojke, 2013), so it is not surprising that it captures the imagination of 
researchers and policy makers (Tanenbaum, 2013). The prevalence of variation is well documented 
(Reid et al, 1999; McPherson, 2008; Wennberg, 2010; McBride et al, 2010; Appleby et al, 2011) as is 
the variation in the productivity of hospitals (Castelli et al, 2014) and the concept remains an issue 
for patients (Birkmeyer et al, 2013). However, few of these publications move the debate beyond 
the undemanding observation and recording of variation. It is rare for commentators to define 
variation and it is uncommon to glean from the reviewed literature what action, if any, could be 
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taken to identify and reduce unwarranted variation. Indeed, no literature could be found to signpost 
readers to appreciate what systematic action could be taken or how the NHS in England should 
respond to investigate, identify and reduce unwarranted variation.  
 
It is acknowledged (Wennberg, 2004) that the continued monitoring and recording of variation 
remains an important process to maintain a spotlight on the concept of variation but it is no longer 
sufficient to accept the repeated observation and sporadic remedies as a way of stimulating action 
to reduce unwarranted variation. More action is necessary if the NHS is to survive the rising demand 
coupled with improvements in medical science and austerity (Maynard, 2011). In response the NHS 
has been challenged to do more and “shine a light on variation in care and unacceptable practice” 
and to share best practice and improve services (DH, 2013). This policy initiative does not specify any 
detail. For example, there is no clear definition; no indication of how the problem should be 
addressed and the policy is silent on which organisation(s) within the NHS should lead the search to 
identify and reduce unwarranted variation. This study will aim to build an evidence base to 
contribute to a better understanding of those challenges by investigating the following three 
questions: 
 
 What are variations in healthcare and why are they important? 
 How should the problem of dealing with unwarranted variation be addressed? 
 What are the perceived barriers to the NHS responding to unwarranted variation? 
 
In order to achieve this objective, the above set of questions will be complemented by a line of 
inquiry which aims to understand whether the appeal from policy makers to reduce unwarranted 
variation is accepted by the NHS, whether the NHS perceives that the lack of a clear definition of 
what constitutes unwarranted variation is a barrier to action being and whether the NHS believes it 
is their role to take action to reduce unwarranted variation. It is postulated that the expanding 
evidence of variation in the provision, costs and uptake of health care implies that unwarranted 
variation remains an issue for the NHS, which is, in part, due to a gap in the level of awareness and 
understanding of the concept of variation. A further aim, therefore, will be to unearth whether the 
NHS considers that training should be made available to better prepare the NHS to be in a position 
to respond to investigate, identify and reduce unwarranted variation. 
 
By exploring these issues, this study will aim to take the debate beyond the powerful, informative 
and ubiquitous observations and recordings of variation, to provide original insightful knowledge to 
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be conveyed in such a way that it can enable policy makers and those in practice to appreciate what 
barriers are preventing action being taken to identify and reduce unwarranted variation. 
 
1.2 WHY THIS RESEARCH IS IMPORTANT 
 
The NHS has been challenged to adapt to evolving demands and improve the quality and safety of 
care as well as the health of the population (Denis & Forest, 2012). There is concern in the wake of 
the financial crisis that the quality and productivity of health care may fall since inevitable cuts to 
health budgets are being made as a means of dealing with the period of austerity and the estimated 
financial gap (Crump & Adil, 2009). In response, the Department of Health together with the NHS 
Commissioning Board team set out four key themes on which the NHS should focus to maximise the 
use of finite resources and to gain better health outcomes. These domains are: quality, innovation, 
productivity and prevention – referred to as the “QIPP programme”. 
 
The QIPP programme started as a centrally co-ordinated initiative, and is now central to planning 
and delivery across all sectors of the NHS. It involves both commissioning and provider 
organisations, with the intention to drive efficiencies across the system by improving service quality 
and productivity (Smith & Charlesworth, 2011). Identifying and reducing unwarranted variation is 
one such initiative to achieve that goal (DH, 2010c). 
 
The issue of variation in health care is not a new phenomenon. Indeed, it could be argued that 
unwarranted variation may have gone unchecked for more than 70 years. Professionals – clinicians 
and managers alike – frequently dispute the existence and classification of variation, often claiming 
fault with the data. Berwick (1991) offers a rationalisation to this dismissive response, reminding us 
that the concept of unwarranted variation is considered provocative, courting polemic views from 
both clinicians and managers. This position is compounded as many defer to their own 
interpretation of a national policy initiative (Coleman et al, 2010) by applying their own definition 
and explanation to justify observed variation, rather than investigate, understand and reduce 
unwarranted variation. Some of the possible reasons for this inertia and perceived tolerance have 
been identified in earlier research, as no clear definition, a lack of leadership and the complexity of 
the challenge (DaSilva, 2012a). 
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1.3 THE TIMING OF THE STUDY 
 
This study is timely with the renaissance of interest in unwarranted variation (Godlee, 2011) 
following the publication of the NHS Atlas of Variation (DH, 2010c) the latest reform programme and 
reorganisation of the NHS and the impact of austerity. This calls on both commissioners and 
providers to develop new ways of working to meet the increasing demands for health care from an 
ageing population with changing needs to deliver a high-quality service from tightening budgets. 
 
This study will explore the phenomenon of variation from both the commissioning and provider 
perspective, seeking to understand the views of these organisations, to appreciate how the problem 
should be addressed and what are the perceived barriers preventing action to reduce unwarranted 
variation. In so doing, the study will aim to take the discussion beyond the descriptive observation of 
variation, to one where new knowledge is created to enable the NHS to respond to the abundant 
and long-lasting problem of unwarranted variation. 
 
1.4 WHY I CHOSE TO DO THIS RESEARCH: A PERSONAL PERSPECTIVE 
 
There are several threads driving this research study. The first is personal and simple: it gave me a 
purpose and a framework to investigate and understand the puzzle of variation in health care. My 
awareness in the subject had been stimulated many years ago, as a clinician, where I sought to 
understand why there were so many different ways health care was being organised and provided 
by different clinicians, mainly doctors and the variety of different modes of treatment they applied, 
with what appeared to be no improvement in outcomes for patients. My curiosity continued whilst 
in senior management roles in the NHS, where adopting a line of appreciative inquiry I would 
explore how best practice could be transferred to improve patient care and wondered what barriers 
were preventing this happening. More latterly, my interest was reignited by the response of the 
NHS, in particular by many senior players, clinicians and very senior managers. “National gurus and 
experts” from all parts of the NHS had a reaction, or to be more precise an abreaction, to the 
publication of the NHS Atlas of Variation series, of which I was a co-author. The response to the 
publication of the first NHS Atlas of Variation (DH, 2010c) was a significant event. It stirred up an 
unstoppable inquisitiveness, moving me to find a channel to focus my time and energy to explore 
the concept of unwarranted variation.  
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My motivation, and perhaps naïve ambition, was to assemble sufficient knowledge to construct a 
credible narrative to enable the NHS system to be able to develop a methodology that should enable 
it to investigate, identify and reduce unwarranted variation. I acknowledge, however, this puzzle to 
be so complex and multi-faceted that any progress in creating a cogent argument for reducing 
unwarranted variation may be slow. Nonetheless, what is clear is that progress will be non-existent 
without a better understanding of why the issue of variation is important, whether the NHS 
considers it an initiative worth pursuing and what barriers prevent the NHS responding. 
 
This study aspires to make a contribution to that understanding and the implications for practice by 
gathering the evidence and uncovering some of those key factors that appear to protract the 
present situation where unwarranted variation continues to be a universal challenge for the NHS in 
England (DaSilva, 2012b). But first, it is important to reflect and understand why the issue of 
unwarranted variation stimulated the policy directive (DH, 2013) requiring the NHS to take action to 
reduce unwarranted variation in health care. This is discussed in Chapter 2, and elaborated further in 
Chapters 4 and 5, thus guiding readers to the genesis and formulation of the main research question 
below. 
 
1.5 STRUCTURE OF THE DOCUMENT 
 
This chapter will now outline the structure of the document. The next chapters of this thesis will lay 
out the context of the study, setting the context of the questions, by reviewing the key themes to 
emerge throughout this five year study.  The first theme is the problem variation presents in the 
uptake, provision and costs of health care; that is followed by the frequent reforms and adherence 
to quasi-market principles in the NHS; which saw the separation of commissioning and providing 
functions within a complex adaptive system with the dynamic relationship between managers and 
clinicians. The context will begin with a review of the concept of variation, its history and the impact 
that the diverse terminology appears to have had on protracting unwarranted variation as an 
unsolved puzzle for more than 75 years. The thesis will present evidence, from the literature and 
findings from this study that the issue of unwarranted variation in health care is not restricted to the 
NHS in England. In fact, it is a challenge facing many countries, each struggling to cope with the 
presence of unwarranted variation and the conundrum of how to reduce it. 
 
 
 
  6 
Chapter 2 – Setting the context 
This chapter will lay out the context of the research study, which is seeking to understand whether 
the centrally driven policy to identify and reduce unwarranted variation can be successful in its 
implementation. The chapter will lay- out and discuss key themes that have emerged throughout 
this study. 
 
Chapter 3 – Developing a conceptual framework 
This chapter will offer an overview of the initial literature review (DaSilva, 2012b) to provide readers 
with an insight into the concept of unwarranted variation and to demonstrate that the study has 
taken account of the available literature and its relevance to this study. A mind- map will be used to 
highlight some of the key themes to emerge from the literature, thus justifying the research 
questions and study. 
 
Chapter 4 – A summary of the research findings so far 
The study has been developed over five years, with primary data collected through the period 2010-
2012, using different methods and sources of evidence of how the NHS responds to variation in the 
provision, uptake and cost of health care. Chapter 4 will offer an overview of the earlier findings, 
including the methods of data collection, and outline the previous investigations, sharing the 
findings that contributed to shaping the research questions and findings for this thesis. 
 
Chapter 5 – Research aims and questions 
Once the context and literature have been shared, the study will reveal the conceptual framework 
assembled from the literature and early findings to test the aims of the research, reminding readers 
of the main research questions and those supplementary questions considered necessary to drawing 
sufficient data to analyse in order to answer the main questions. 
 
Chapter 6 – Research approach 
This chapter will offer an insight into the methodology, including a justification for using a mixed 
methodology. This will be supported by the declaration of the theoretical position and disclosure of 
the ethical issues considered, and adhered to, throughout this study. This will be followed by 
clarification of the research design, approach and methods of data collection. 
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Chapter 7 – Findings and analysis 
Chapter 7 will share the finding and analysis, displayed for ease by following the three main 
questions. This chapter will present the findings, using tables and figures to support the text which 
will offer a discussion of the interpretation of the findings and a brief summary at the end of the 
chapter. 
 
Chapter 8 – Discussion and implications for practice 
This chapter will draw all the previous work together in a broad discussion using the findings to 
guide suggestions for future research and the implications for practice. 
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Chapter 2: Setting the context 
 
2.1 INTRODUCTION 
 
This chapter will lay out the context of the research study, which is seeking to understand whether 
the centrally driven policy to identify and reduce unwarranted variation (DH, 2013) can be successful 
in its implementation. The policy initiative does not offer clarity on “how” or “who” and is equally 
shy in defining which organisation(s) should lead the search for and reduction of unwarranted 
variation, a position that stimulated the research questions above.  
 
The study will draw on the literature and findings from earlier research (DaSilva, 2012b; 2012c; 
2013), which have become focused on the four following key themes. 
 
Figure 1 – Key themes 
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2.2 VARIATION – THE PROBLEM  
 
The start of the journey can be traced to Glover (1938), whose concern was that there was an 
inexplicable eightfold variation in the rates of tonsillectomies amongst school children with what 
appeared to be no real health gain. Perhaps of more concern to Glover was that these operations 
were being performed as a “routine prophylactic ritual, with no particular reason”. Glover’s paper 
offered clues that at the time of publication it was possible to take some action to reduce those 
variation rates in those operations: 
 
“On a larger scale was the courageous reduction in Derbyshire initiated in 1932 by Dr. Ash. In 
this county area the operations in 1931 were 2,626, or 3.9% of all the 68,079 children in 
average attendance. In 1929 the number had been 2,240, and in 1930, 2,316. Dr. Ash 
reduced the numbers to 1,187 in 1932; 523 in 1933; 156 in 1934; 178 in 1935; 193 in 1936; 
164 in 1937. If the 1931 rate had been maintained, some 15,700 further children would have 
been tonsillectomised since the reduction began.” 
 
However, Glover (1938) does not offer any reason why this reduction was possible although he does 
infer that it may have been in response to the strong medical leadership of the time, which is 
considered essential today if action is to be taken (Ireri et al, 2011), particularly as there is the 
suggestion that the cause of most variation can be laid at the feet of doctors (Wennberg, 2010). 
 
The following mind map (Appleby et al, 2011) reveals the complexity of the problem variation 
presents and is perhaps one of the reasons why the topic remains an unsolved puzzle for the NHS. 
Central to this mind map is the phenomenon of variation, which needs to be considered with the 
appreciation that clinicians, managers and patients all respond to variation to meet their own aims 
(Neuhauser et al, 2011) and may, therefore, interpret this mind map differently. Some of the key 
themes, drawn from the earlier literature review and findings of earlier research (DaSilva, 2012b; 
2012c; 2013), are highlighted to signpost readers to the genesis of the research questions and how 
they have been formulated from recurring key themes. 
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Figure 2 – Mapping causes of variation 
Source: Appleby, J., et al. (2011). Variations in Health Care: The Good, the Bad and the Inexplicable. 
London: King’s Fund. 
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2.2.1 Defining variation 
 
As explained in Section 1.1, the concept of variation is frequently separated into either warranted or 
unwarranted variation. It is important to acknowledge that there is no single definition for either 
and these classifications should, therefore, act only as the stimulus for a deeper exploration of the 
topic, particularly as a value judgement is often attached branding variation as being either good or 
bad. Noticeably, McPherson et al (2013) warn against this simple assumption by raising two 
important issues. The first is that it is not right to use data alone to determine which rate is “right” 
and the second is the suggestion that the presence of variation is a sign of health service delivery 
problems. We should also remember that not all variation is bad – if it were, it would be easier to 
take action (Mulley, 2009) – and that some variation will become ever more likely as professionals 
perform above the mean (Thomson, 2002), the implication being that some variation is inevitable, as 
well as random, and perhaps an outcome of innovation and improvement, which are essential pillars 
of a modern health care system. 
 
It is disappointing, however, that much of the literature does fail to offer a clear definition when 
referring to the two classifications, rendering those studies incomplete (Mercuri & Gafni, 2011). Of 
equal concern are the many interchangeable descriptions, for example: unintended variation 
(Berwick, 1991), inappropriate variation (Cabana et al, 1999), warranted variation (Mulley, 2009), 
unexplained variation (Richards, 2009) and unwarranted variation (Wennberg, 2010). Bojakowski 
(2010) believes that the creation of a definition should be a democratic or consensus building 
process and goes on to offer a simple and pragmatic definition of unwarranted variation, by broadly 
adopting Wennberg’s description, claiming that unwarranted variation is the differences in care 
which cannot be explained by public health needs or medical needs. 
 
For clarity and completeness, a definition for this study has been adopted from Wennberg (2010), 
who claims that “unwarranted variation is where there is a variation in the utilisation of health care 
services that cannot be explained by differences in patient illness or need or choice”. Adopting this 
definition is considered reasonable; after all, it offers clarity, is simplistic and it is not over-clouded in 
myth or professional jargon. 
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2.2.2 An International Problem 
 
It is acknowledged that it is difficult to make objective comparisons of international health care 
systems without paying attention to some of the fundamental differences, for example the model of 
care and the ways in which health care is accessed, funded or provided. What is clear, however, is 
that the literature reveals that variation remains a puzzle, both internationally and intra-nationally, 
for many health systems (McPherson et al, 2013). This further supports the importance of this study, 
obliging a deeper examination of this complex area of health care policy. 
 
2.3 VARIATION IN A COMPLEX ADAPTIVE SYSTEM 
 
The concern about variation creeping into the NHS was as alive at its birth as it is today, 
demonstrated in the statement of the architect of the NHS, Aneurin Bevan, who claimed that “we 
have got to achieve as nearly possible a uniform standard service for all – only with a national 
service can the state ensure that an equally good service is available everywhere” (Allsop, 1984). 
 
The NHS was born on July 5th 1948 and delivered with the principles of fairness, free at the point of 
delivery and available for those in need (McBride et al, 2010) with, at the time of its conception, an 
open ended commitment to meet those needs, with no specific resource allocation policies (Allsop, 
1984). Since 1948 to the present day, the NHS has remained a centralist establishment and any 
fragmentation would seem a paradox to anyone who still thinks of it as a unitary governmental 
system (Garber, 2011) despite the many claims of decentralisation. The “centre” does remain 
responsible for making policy, resource allocation, albeit on the basis of nous and intuition during 
periods of austerity (Fisher, 2007) and performance monitoring whilst the service side is responsible 
for front line delivery of care. The relationship the between the “service side” and the “centre” is a 
chequered one, compounded by the frequent claims and attempts to decentralise, as described by 
Allsop (1984), in the very first NHS circular [HC/RHB (47) 01] sent from the Minister of Health, 
Aneurin Bevan, to regional hospital boards. Bevan claimed that the service side should: 
 
“feel from the outset a sense of independent responsibility”. 
 
However, it is important to remember that the NHS is not the monolithic organisation it was in 1948; 
it is now more akin to a complex adaptive system (Plsek, 2000) where controls are diffuse, actions 
are unpredictable and the interaction between system agents is flexible, enabling organisations to 
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self-manage change (Kernick & Sweeney, 2001), making a centrally driven policy to identify and 
reduce unwarranted variation more of a challenge. There are many claims, fuelled by hope and 
rhetoric to devolve and decentralise power, which is often presented as the magic bullet to address 
problems within the health system (Saltman et al, 2006) and is an aspiration that has dogged the 
NHS as it attempts to shift from a centralist, hierarchical and bureaucratic organisation towards a 
network (Exworthy & Frosini, 2008) or a market (Lewis & Dixon, 2005). The ceaseless centralisation 
of power, however, maintains the NHS as a dynamic political environment leaving it open to 
frequent reform and change (Klein, 2010), demonstrated by the most recent reorganisation in April 
2013, described in detail in the white paper “Equity and Excellence: Liberating the NHS” (DH, 2010a). 
This white paper laid out a reform programme that was specifically designed to deliver a fresh 
perspective to improve the commissioning (or purchasing) side of the NHS, through a significant 
reorganisation of commissioning organisations, a change which, more or less, left the provider, 
monitoring and regulatory structures unchanged; an issue which will surface again later in Chapter 7 
as the findings from this study are revealed. 
 
It is worth pausing here to consider the centralisation of the NHS, the many attempts to decentralise 
and the public perception of the NHS. Regardless of the attempts to devolve power demonstrated by 
the many self- governing organisations within the system it is not inconceivable that the public 
perception of the NHS continues to be that of a single monolithic body – one national organisation 
with direct control over all aspects of care. This perception may be justifiable, built on the premise 
that the notion of belonging to and working for the NHS has implied some kind of solidarity, referred 
to as “a family” (Checkland, 2012) with a commonality of purpose and experience and a sense of 
national pride, positioning the NHS as the closest thing to a religion (Delamothe, 2008). However, 
the reality is quite different; the NHS today is a multifarious set of organisations, all of which 
maintain an irresistible trend to bureaucratise (Woods, 2010), many with their own governance 
arrangements and accountability to different national regulatory jurisdictions, with ultimate 
accountability to central government through the Secretary of State for Health. 
 
That complexity makes the identification and reduction of unwarranted variation a bigger challenge 
for the NHS. Nonetheless, the important call has been made, via the instrument of policy, that the 
NHS should reduce unwarranted variation. For that initiative to be successful, clinicians and policy 
makers must find the competence, curiosity and courage to confront variation (Mulley, 2009), and 
this study is seeking to make a small contribution to understanding that challenge. 
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2.4 REFORMING THE NHS 
 
The previous section has demonstrated that the NHS is far from a monolithic organisation. Instead, it 
is more a system – a description that is becoming more common – albeit a complex adaptive system 
that hides the organisational arrangement of cultures, sub-cultures and networks (Plsek, 2000). This 
complexity is compounded by frequent upheavals through constant reorganisations (Klein, 2010) 
and reforms, of which the unforeseen consequences and dysfunctional effects (Edwards, 2010) are 
considered to outweigh any benefits (Dunbar, 2011). These programmes of reform may be designed 
to cultivate a managerial rather than political agenda, as characterised in the latest reforms outlined 
in “Equity and Excellence: Liberating the NHS” (DH, 2010a), which again cushioned a reorganisation 
by the claim that it was planned to decentralise power (Millar et al, 2011). 
 
This may be a case of history repeating itself. There was a similar proclamation of the reform 
programme of the 1980’s, with the acknowledgement that, at that time,  there were wide variations 
in the cost of treatment, waiting times, prescription and referral, and a programme of reform was 
crafted as a way of dealing with those pressures. The proposal, at that time, was to raise 
performance, improve management and delegate responsibility (Greener et al, 2011), which marked 
two major reform initiatives, one at either end of that decade. The 1980’s saw the start of many 
management reforms and reorganisations as illustrated in Table 1. One of the significant reforms 
was outlined in the Griffiths report (Department of Health and Social Security [DHSS], 1983), which 
introduced the notion of managerialism. These reforms were a direct challenge to the dominant role 
of the professionals and the way they organise themselves (NHS Institute, 2008). The second set of 
reforms at the end of that decade saw the introduction of the purchaser (later referred to as 
commissioner) and provider split (DH, 1989). Relative to this study, both these initiatives were 
characterised as a drive towards increased efficiency and are important in setting the context for this 
study as they introduced the purchaser/provider split and the issue of managerialism and 
professionalism, which are discussed later.  
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Table 1 – Significant NHS reforms and reorganisations, 1982-2010 
Year Legislation/documentation Implications to NHS 
1982 Reorganisation Abolition of area health authorities; reconfiguration 
of regions and 192 district health authorities; 90 
family practitioner committees remained unchanged 
1990 NHS and Community Care Act Reconfiguration of NHS; health authorities 
established to oversee NHS trusts and general 
practitioner (GP) fundholding introduced, overseen 
by family health service authorities (FHSAs); 
introduction of purchaser/provider split 
1994 The NHS: A Service with Ambitions – 
Primary Care Delivering the Future 
Health authorities reconfigured to 8 and FHSAs 
dissolved with responsibilities transferred to new 
health authorities 
1997 The New NHS: Modern, Dependable 
NHS Primary Care Act 
GP fundholding abolished; new models of primary 
care provision and choice established 
2000 The NHS Plan Abolition of NHS Executive; Department of Health 
and Social Care (DHSC) established 
2002 Shifting the Balance of Power within 
the NHS 
DHSC dissolved and 96 health authorities abolished 
with the creation of 28 strategic health authorities 
(SHAs); 303 primary care trusts (PCTs) established 
2004 The NHS Improvement Plan 
Commissioning a Patient Led NHS 
Practice Based Commissioning: 
Engaging Practices in 
Commissioning 
First 10 foundation trust (FTs) established; plans to 
widen practice-based commissioning 
2006 Our Health, Our Care, Our Say SHAs reduced from 28 to 10 and PCTs merged from 
303 to 151 
2008 Our NHS, Our Future Reorganisation dismissed as an option for 
improvement but PCTs directed to separate 
purchasing and provision arms 
2010 Equity and Excellence: Liberating 
the NHS 
Significant reorganisation of NHS structures; 
abolition of SHAs and PCTs, and creation of the NHS 
Commissioning Board, Public Health England, NHS 
Trust Development Authority and 303 clinical 
commissioning groups 
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2.4.1 The separation of commissioning and providing in the NHS 
 
The white paper “Working for Patients” (DH, 1989), separated the NHS into two congregations: 
purchasing and providing. The driver of that policy was to introduce market principles into the NHS, 
jolting the NHS into a new paradigm (Enthoven, 1990) where competition would play a key part in 
the planning and delivery of care and where purchasers would tender out contracts for provider 
organisations to secure. The ambition was that market principles would lead to greater efficiency by 
rewarding efficient providers, who could then increase their revenue from an increase in activity by 
gaining more contracts (Day & Klein, 1991). The introduction of the market, however, has not been 
welcomed by all. Some claim that the formation of the purchaser/provider split has had a 
dysfunctional and disruptive impact on health care services (Ferlie, 2010) claiming that the 
introduction of market principles heralded the end of the NHS, with its death fixed with some 
precision at the publication date of the 1990 white paper (Klein, 2010). The structure of the 
purchaser/provider split has rarely been stable due to the frequency with which the NHS is 
reorganised (Hunter, 2012). These constant upheavals, or “re-forming and deforming” (Paton, 2013), 
are not always popular and bring with them unintended consequences, such as ruptures in long-
term relationships (Chambers et al, 2013), which may breed the inertia around taking any action to 
reduce unwarranted of variation. 
 
In 1997 the new Labour administration wanted to distance itself from the notion of market 
principles within the NHS, referring to collaboration rather than competition (Knapp et al, 2001) and 
the unambiguous claim that there were no serious purchasers in the NHS (Light, 1998). The 
purchaser/provider split was, however, retained with purchasing being reframed as commissioning, 
which has become something of an obsession (Smith et al, 2013). Sharing ground in the same quasi-
market as providers, commissioning organisations continue to hold responsibility for some provision 
of services and are also expected to embrace a proactive strategic role in planning, designing and 
implementing a range of services required for a designated population (Woodin, 2006). These 
arrangements and the declared weakness of commissioning led to a further complexity within the 
NHS. This was distorted by the power retained by the main provider organisations, some of them 
giants of the NHS, which made the practice of commissioning immensely difficult (Jones & Wood, 
2010) – more so, as it remains a largely neglected and under-developed process (Wade, 2011). 
 
One of the obsessions of commissioning in the NHS has been to place clinicians at the heart of that 
process. Indeed, the current policy initiative (DH, 2010a) places GPs and clinicians at the head of the 
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commissioning table (Reynolds & McKee, 2012), a practice that draws a warning that it can only be 
achieved by extending the gate keeper and role of healer of GPs to encompass the role of 
commissioner with full budgetary control (Smith & Mays, 2012). This obsession is not new (Gridley, 
2012), we are reminded that indicative budgets were offered to entice GPs to volunteer to 
participate in commissioning under the policy of fundholding (Neal, 2005). This policy turned out to 
be one of the most controversial parts of the internal market reforms (Dusheiko et al, 2008) and the 
return of clinicians to the forefront of commissioning could suggest that policy makers do not seem 
to have learnt the lessons from fundholding (Roland & Rosen, 2010) where many clinicians generally 
avoided assuming roles that appear to be politically orientated and dominated by managers. This is a 
concern that has been crystallised since the introduction of managerialism, which retains a division 
of labour between managers and the powerful and influential professionals. 
 
2.5 THE INFLUENCE OF PROFESSIONALISM AND MANAGERIALISM ON VARIATION 
 
The dynamic relationship of managers and professionals has led to tension for many years as doctors 
have rarely seen eye to eye on what a health service should provide and how it should be managed 
(Winyard, 2003), with both parties wrestling for control as the medical profession exerts control and 
usurps illegitimate power (Illich, 1988). Freidson (1994) would claim that by usurping this power, 
doctors send a signal that the medical profession would rather serve themselves than the interests 
of the patient as they try to preserve their professional power and boundaries. This is a controversy 
that the Thatcher government attempted to address through the Griffiths report (DHSS, 1983). 
 
Public bureaucracies sustain a fine balance of decision making between professionals and managers 
(Cardinalaels & Soderstrom, 2013). This is particularly true in medicine, where the norm of medical 
practice is so loosely defined that it allows too much ambiguity (Wennberg, 1984). Professionals 
have a distinctive and special way of controlling organisations, their work and the workers (Evetts, 
2011) to promote and control the cultural (Michalec & Hafferty, 2014). The Griffiths review of NHS 
management (DHSS, 1983) was commissioned to address this perceived grip of medical dominance 
and the perceived lack of management accountability, performance measurement and NHS 
responsiveness. The review was an attempt to de-stabilise the power that the medical profession 
held (Day & Klein, 1991) and a means to penetrate medical “tribalism” (Hunter, 1996) by honing in 
on the “holy grail” of clinical freedom by asking who was responsible for clinical effectiveness. 
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Prior to the implementation of the Griffiths report in 1983, the NHS was run by the medical 
profession who were supported by administrators. The introduction of managerialism, however, did 
little to break down the power held by the professions; consultants retained their autonomy and 
power by being able to set the standards of performance against which they could be measured, as 
well as the means by which they were held to account for them, leading to claims that although 
Griffiths’ diagnosis was right – declaring that the NHS required a better grip of management to 
manage the dominance of the professionals – there are suggestions that his treatment was too 
vague because the policy initiative lacked any bite (Day & Klein, 1983). The consequence of Griffiths’ 
review was little change; managers were unable to become more proactive and strategic because of 
their lack of control over clinicians as doctors rejected new managerialism as a programme to 
impose controls (Som, 2005) and to turn the attention of clinicians onto managerial issues, rather 
than clinical matters (Freeth et al, 2008). Spence (2010) confirms this notion, suggesting that the 
freedom of professionals and the power they retained has changed little since the Griffiths review; 
managers continue to attempt to control costs and measure activity, a behaviour that only draws 
condemnation from the medical profession. 
 
There have been other efforts, some move covert than others, to wrestle control away from the 
professionals. One such attempt was the introduction of market principles (Flynn,2012) applying a 
covert set of behaviours using tools and processes, for example, performance management, audit 
and regulation to act as a shield of bureaucracy to constrain medical dominance, (Mannion, 2009). 
More recent efforts have been attempted through a new democracy of health care that introduces 
patient choice and consumerism. However, as Kelleher et al (2013) note, each time these attempts 
have been made, they are easily brushed aside by clinicians. Brody (2010) believes it because they 
enjoy too much freedom to dominate health care. This reluctance to take account of variation in 
clinical practice removes it from the day-to-day concerns of clinical staff, making it a management 
driven exercise (Degeling et al, 2004). However, the idea that clinicians’ behaviour is a contributing 
factor to causing and sustaining unwarranted variation is fiercely disputed by medics as they defend 
their practice, possibly through fear and a lack of understanding (Berwick, 1999).  
 
In summary, it is suggested that any action to identify and reduce unwarranted variation will need to 
gain both clinical and managerial interest as well as harness support from both groups to align the 
required technical, political and regulatory solutions (Knickman, 2004). This will not be an easy 
undertaking; it will need to be handled sensitively, acknowledging that clinicians continue to hold a 
dominant position in the NHS, regardless of the attempts by politicians and others to bring a 
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balanced and more democratic distribution of that power. This position remains one of the 
fundamental themes of this study as demonstrated in the following literature review, which will 
focus on the common themes emerging out of this study. 
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Chapter 3: Developing a conceptual framework 
 
3.1 A LITERATURE REFRESH 
 
A literature review, submitted in part fulfilment of the doctorate, explored the concept of variation 
in health care in detail (DaSilva, 2012b). This chapter will re-establish some of the knowledge 
gleaned from that review with attention paid to those key themes that have not been refreshed in 
the previous chapter. It will also introduce the findings to emerge during the course of this study 
(DaSilva, 2012c; 2013. 
 
The literature confirmed that variation remains endemic (Dodgion & Greenberg, 2009) with many 
articles published (McPherson et al, 1986; Ham, 1988; Berwick, 1991; Casparie, 1996; Wennberg & 
Wennberg, 2003; Appleby et al, 2011; Castelli et al, 2014) since the seminal paper (Glover, 1938) 
identifying the presence of variation in health care across demographic groups, geographic areas, 
institutions and even within individual health care providers. The examination of the literature also 
identified variation between GPs and practices, in areas such as the frequency of contacts, 
diagnostic test ordering, referrals, prescription rates and follow-up appointments (de Jong et al, 
2006). 
 
Much of the literature has focused on specific clinical conditions or interventions (McPherson, 2008; 
McPherson et al, 2013) whilst others have researched for any association between health care 
system resources and utilisation rates (Appleby et al, 2011). A handful of studies suggest that some 
progress may have been made in addressing variation, using variation as an indicator for quality 
improvement and in patient safety (Leggat et al, 2011). However, the majority of the literature 
reviewed confirms that the past 40 years have seen health care research in this area largely focused 
on the identification and measurement, rather than the management or reduction, of unwarranted 
variation in health care. 
 
It is, therefore, perhaps not surprising that no new literature could be found to describe, or give any 
indications regarding, how the NHS should respond to the problem of variation or what barriers 
prevent the NHS taking action to  reduce unwarranted variation, endorsing the importance of this 
study. Indeed, the literature frequently fails to offer a clearly articulated rationale, or argument, as 
to why dealing with variation is considered important although we are reminded that it is, after all, 
the hallmark of poor quality (Hannan, 1999), leading to waste and duplication (Wennberg, 2010, DH, 
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2010c; 2011). This study will aim to close that knowledge gap, using findings from previous research 
and the recent literature review, which established the key themes discussed earlier, and the recent 
literature review other themes were identified as illustrated in the mind-map below.  
 
 
Figure 3 – Mind map of key themes 
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3.1.1 The concept of unwarranted variation 
 
The literature review established that the concept of variation is perplexing and confusing DaSilva, 
2012b). This is compounded by the lack of a clear definition to describe those variations considered 
unwarranted and any rational case for the NHS to take action. Thomson (2002) invites us to reflect 
on the call to action, asking what the problem is with variation, reminding us that if a policy is not to 
become lost in translation, a case of need and supporting actions will have to be explained in clear 
terms. DaSilva, (2012b) cited Toulmin’s theory (2003) of creating the right argument as a way of 
helping us to shape that claim and create the right narrative to act.  
 
Toulmin’s framework was proposed as a way forward as the failure to act may be due to failure to 
explain why it is important for the NHS to take action to reduce unwarranted variation. The 
suggestion was that the creation of a clear narrative needed urgent consideration and that Toulmin’s 
framework offered a well-ordered way to deconstruct the phenomenon of variation and present the 
case for why the NHS should reduce unwarranted variation. However, the support for Toulmin’s 
framework did not come without the caveat that the model is not a linear description of a problem 
but a dynamic and functional process to frame and re-frame the narrative to create and maintain a 
persuasive argument to galvanise professionals into action with a shared goal to unite the interest 
and activities which is critical to any success, (Porter, 2010). 
 
Thus far, the literature has implied that it is rare for commentators to examine the breadth and 
depth of the issue (de Jong et al, 2006), conveying an air of inertia rather than a curiosity to act, as 
encouraged by Mulley (2009). It has been suggested that the right argument has not been 
constructed to galvanise the NHS to take action. One part of that process will be to offer a clear 
definition. 
 
3.1.2 Defining unwarranted variation 
 
The simple declaration of the existence of variation, combined with the interchangeable 
descriptions, has been highlighted throughout the review of the literature which does not offer 
much assistance in resolving the challenge to understand what action should be taken and what 
barriers prevent that action. As a reminder, this study adopted Wennberg’s (2010) definition of 
unwarranted variation, as that which cannot be explained on the basis of illness, medical evidence or 
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patient preference. However, it is important to appraise the faithful acceptability of his work; if only 
to be assured that we are not blinded by the claims made by those supporters of Wennberg. 
 
The influence that Wennberg and colleagues has made should not be underestimated, nor should it 
go unchallenged. White (2011) acknowledges the great work of Wennberg but raises a challenge 
with a claim that Wennberg’s work is only half of the story. The literature offers a definition 
(Wennberg 2010) but fails to offer any compelling policy ideas on what to do about those variations, 
implying it is because those decisions may be unpalatable. This study will pick up on the challenge 
laid by White (2011) and seek to nudge the debate forward to use the findings of this study to 
consider the implications for practice and to propose a way forward, palatable or not. 
 
3.1.3 The role of clinical guidelines in reducing unwarranted variation 
 
The literature reveals that guidelines have been developed for many years (Grol, 1992) as a process 
to increase efficiency (Conroy & Shannon, 1995), assist clinicians make appropriate decisions 
(Siriwardena, 1995), improve quality (Lugtenberg et al, 2011), decrease inappropriate variation 
(Cabana et al, 1999) and as a potential tool to decrease unjustified variation in treatments (Cluzeau 
& Littlejohns, 1999). The uptake of guidelines is acknowledged as being an effective tool for reducing 
variation in health care and costs by improving the quality of patient care (Grimshaw et al, 2004; 
Rashidian et al, 2008), and they are considered the most common initiative to reduce unwarranted 
variation in clinical practice (Kennedy et al, 2010). However, they do carry their own health warning 
with reminders that physicians are not always keen to follow guidelines (de Jong et al, 2010; Carlsen 
& Bringedal, 2011). 
 
Clinical guidelines can been defined as being systematically designed accounts that translate the 
findings of research into best practice, in order to assist clinicians find the most appropriate care for 
reducing variation in health care (Spyridonidis & Calnan, 2011). The effectiveness of implementation 
is challenged (Gundersen, 2000) and with an eye to the earlier warning that doctors and hospitals 
resist guidelines as “cookbook medicine”, which threatens the art and autonomy of medical practice 
(Berwick, 1991), it is unsurprising that guidelines cause such emotional discord. One reason for this 
distrust of guidelines is that clinicians frequently question the evidence base, which in turn becomes 
a barrier to implementation (Spallek et al, 2010). As many are connected to the drug industry 
(Tanne, 2005), there is also concern that guidelines create perverse incentives, which is likely to 
increase variation rather than reduce it. Nonetheless, that concern needs to be balanced with the 
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awareness that guideline development has been successful in challenging unjustiﬁed variation in 
clinical practice by shifting the locus of clinical decision-making towards  high-quality care (Sheldon, 
2005). This was proposed as a method of keeping physicians up to date and reducing unwarranted 
variation (Enthoven, 2009). 
 
Lugtenberg et al (2011) suggest that barriers to adherence of guidelines lie not only with the clinician 
but also with the patient as well as the organisational context and the culture of the system. This is a 
sentiment not lost on Berwick (1991), who warns of the potential of misuse, with good reason as 
guidelines may become politicised and impractical, leading to concerns about the uniqueness of an 
individual patient (Carlsen et al, 2007). 
 
3.1.4 The introduction of market principles and the purchaser/provider split 
 
This topic was introduced in Chapter 2, but a fresh review of the literature regarding the 
purchaser/provider split is presented here. Gubb and Meller-Herbert (2009) argued for keeping 
health care away from market conditions, claiming that health care is central to humankind and also 
has high upfront costs. This claim is reinforced by Allen (2013) who claimed that it is not possible to 
construct a market conforming to classical economic principles in respect of health care. Regardless 
of these warnings, the policy for a market within the NHS has been maintained by successive 
governments and the conundrum here is whether variation in health care has gone unchecked for so 
long, with precedence given to the formation and maintenance of a quasi-market and many re-
organisations. 
 
The literature reveals that the development of an internal market has offered benefits, for example 
opening up new information and data sources, creating a database capable of generating the 
necessary information required to operate the new system (Day & Klein, 1991). This is considered 
one of the essential steps necessary to address unwarranted variation (Sipkoff, 2003; DaSilva, 2013). 
However, Klein (2010) challenges this, suggesting that the introduction of market conditions has 
highlighted an asymmetry in the information available to purchasers (commissioners) and providers, 
with it favouring the latter, where information is power. 
 
That perceived preferential position for providers goes beyond data and information; the structure 
of the provider side of the NHS has remained fairly static over recent years, unlike the 
commissioning side, which has been constantly reconfigured. Reforms of the provider side have 
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been around the policy changes to increase diversity of providers and increase the notion of 
competition (Allen, 2009), where providers have been encouraged to develop a semi-autonomous 
function of self-governance, frequently denounced as privatisation by another name (Day & Klein, 
1991). This policy has received a bad reaction from both professionals and the public (O’Dowd, 2011) 
as it forces provider organisations to compete with each other for contracts, This is considered a 
barrier for any provider to seek out unwarranted variation as the priority is on gaining contracts and 
increasing activity. This is an unforeseen consequence that increases variation (Wennberg et al, 
2008) as more resources are made available on the supply side; a point illustrated by their reflection 
on practice in areas where there are more cardiovascular surgeons, more cardiovascular surgery is 
performed, regardless of need. 
 
However, evidence about the supply side in the English NHS shows that there has not been a large 
amount of competition between suppliers (Propper et al, 2008) although there has been a marked 
evolution of the provider sector, which is constructed to survive in market conditions. This is 
exhibited no better than through the introduction of the foundation trust movement and the policy 
designed to extend patient choice and increase of supply through the independent sector treatment 
centres. In 2007 the NHS saw funds directed to the use these facilities, with SHAs judged by the 
impact their PCTs had on setting contracts with private providers (DH, 2007). Pollock & Godden 
(2008) remind us that the DH failed to collect or provide any useful data to evaluate that policy 
suffice to say it reduce any opportunity to manage supply. Allen (2009) concludes that the policy of 
competition is too optimistic about the benefits and does not show enough concern about the 
undesirable consequences. 
 
Furthermore, there is a suggestion that commissioning organisations are considered weak in relation 
to providers (Abbott et al, 2009) and do not “fit” into the structures and process of the NHS 
(Checkland, 2012). This creates a tension between the provider side and purchasing/commissioning 
side of the NHS, which has become a long-established encounter, with considerable critical 
comment aimed at the process of commissioning (Black, 2010). Commissioning, however, has also 
been described as behaviour, not a process (DaSilva, 2012a), exhibited through a multiplicity of 
relationships within a complex system that needs to be considered separately from the traditional 
image of purchasing. The current focus for commissioning is directed towards engaging GPs, under 
the headline of “clinical commissioning”. This is a worrying trend as an earlier evaluation of GPs and 
commissioning (Smith & Mays, 2012) suggested that GPs were as likely to focus on structures and 
process, and there is little to suspect that this might change. Whilst it may be simplistic and more 
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comfortable for GPs to focus on structures again, that will not achieve the ambition of the 
government to improve clinical commissioning (Ellwood, 1997; Abbott et al, 2009). 
 
3.2 MOVING THE DEBATE FORWARD 
 
The literature reveals that it is rare for commentators to offer a solution to the persistence of 
variation. One of the few papers to propose a way forward was published more than a decade ago 
(Sipkoff, 2003). This suggested there were nine steps necessary to a health system reducing 
unwarranted variation. Although this paper refers to the American health system, the steps do 
translate to the NHS in England. The important link to this current study is that Sipkoff’s publication 
appeared at a time that saw the implementation of the “NHS Plan”, which launched a target driven 
culture within the NHS by laying down definitions and measurement processes for a list of targets 
where the results of achievement would be made public. This was considered a high-octane 
mechanism for altering provider organisation and clinician behaviour (Stevens, 2004). Interestingly, 
of all the targets developed, the literature does not reveal any assistance in identifying those that 
were specifically aimed at identifying or reducing unwarranted variation. That intention was more 
covert and process orientated, ironically leading to variation of implementation (Drennan et al, 
2011). Furthermore, Gravelle et al (2007) concluded that the interpretation of such a target 
orientated process introduced an additional range of services into primary care without an 
associated reduction in hospital admissions, perhaps an unforeseen consequence of the policy – an 
increase in variation. 
 
The symmetry from the period of Sipkoff (2003) and present day is that confusion remains amongst 
NHS leaders about whether to create a definition for unwarranted variation or whether guidelines 
would help to reduce unwarranted variation. These are two concepts that have become common 
themes throughout this study and warrant further exploration alongside another key theme: 
reorganisation. It is of concern that at the time of the publication of Sipkoff’s paper in 2003, the NHS 
was undergoing a significant reorganisation, scrapping district health authorities and replacing them 
with new organisations to be responsible for commissioning services for a defined population. It is of 
more concern that the NHS has since reorganised again, not once but twice, in the same decade, 
perhaps protracting the inertia the NHS exhibits about the concept of variation. This refreshed 
literature review will now begin to focus on those key themes uncovered from the findings of the 
research so far (DaSilva, 2012c; 2013), which have assisted in shaping the research questions. 
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3.3 SUMMARY 
 
The ambition for the NHS to identify and reduce unwarranted variation, set against the backdrop of 
the historical tensions brought about by the conflicting priorities of the purchaser/provider split is 
challenging. This literature review has demonstrated that the any potential solutions go well beyond 
the constant structural change and reforms, confirming the claim that until recently policy makers 
and managers have concentrated on only a part of the problem presented by variation (Wennberg, 
2010). 
 
Several key themes have surfaced throughout this study, drawing the conclusion that there is no 
doubting that variation in health care is a problem as much today as it has been since before the 
introduction of the NHS, with variation observed in many procedures and across many sectors of 
health care. Of more concern, however, is that few commentators explore what to do about 
variation and how to move beyond the identification of unwarranted variation to taking action to 
reduce it, as required through the NHS Mandate (DH, 2013). These key themes offer a focus for this 
study, which is aiming to attain new knowledge and shed light on the puzzle presented by 
unwarranted variation. Each of the themes remains a separate piece of the jigsaw, each with its own 
issues and challenges, but progress needs to be made to create the right argument to why and how 
the NHS can piece that puzzle together, where each of the themes can complement the others and 
where the dynamics of the complex system can function cohesively to identify and reduce 
unwarranted variation. This study aims to make a contribution to solving that puzzle by exploring 
why variation is a problem, how the NHS should address that problem and what barriers are 
preventing action being taken to reduce unwarranted variation. 
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Chapter 4: A summary of the research findings so far 
 
4.1 INTRODUCTION 
 
The research study has been developed over five years, with primary data collected through the 
period 2010-2012, to provide fresh insight on how the NHS responds to variation in the provision, 
uptake and cost of health care. This chapter will share the methods and findings of earlier research 
that contributed to shaping the research questions for this thesis. 
 
4.2 OVERVIEW OF THE STUDY TO DATE 
 
This study has applied both qualitative and quantitative methods to explore the concept of 
unwarranted variation. It has established that the concept of variation remains an unsolved puzzle, 
with no clarity of the action required, by which discipline or organisation, to identify and reduce 
unwarranted variation. This is a position that deserves further exploration and investigation. By way 
of background it is considered beneficial to provide a summary of the methods and findings from 
earlier research (DaSilva, 2012b; 2012c; 2013) starting with a piece of qualitative research, 
introduced by a review of the perception of qualitative research in the NHS. 
 
Qualitative research is often dismissed as not being the traditional method in the NHS (Silverman, 
2010) as it is not considered as robust as quantitative research. Accordingly, the position of 
qualitative research was evaluated to offer assurance that the findings from the study could be 
reasonably interpreted and offered as useful, thus mitigating any challenge to the findings through a 
simplistic recourse to challenge the methodology (DaSilva, 2012c). In summary, that evaluation 
concluded that qualitative research is of equal importance – and indeed complements quantitative 
research (Grol et al, 1992; Grypdonck, 2006) – and that researchers should strive to prevent 
methodological separatism and supremacy (Malterud, 2001). Furthermore, the benefits of 
qualitative research are finding favour as a method of supplementing quantitative research, for 
clinical, organisational and policy decision makers, particularly when studying a complex 
phenomenon (DaSilva, 2012b). 
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4.3 SUMMARY OF DOCUMENT 3 
 
This study adopted purposive sampling, sometimes referred to as non-probabilistic sampling, 
justified as a sound technique to study required special or unique cases. It is employed when the 
individual case itself, or a specific group of cases, is a major focus of the investigation (Teddlie & Yu, 
2007). The access to special cases in this study was by interviewing a number of executive members 
of the NHS Commissioning Board and a number of leading GPs in the forming CCGs.  
 
The literature review had established the main themes, which were used to outline the structure of 
a set of semi-structured interviews. Care was taken to ensure the interviews were carried out 
according to high ethical standards, offering confidence to the subjects and ensuring that they were 
fully aware of the purpose and methods of the research. Subjects were reminded that they could 
withdraw at any point. An outline of the areas to probe was constructed to ensure that questions 
flowed and that each of the topics was covered. 
 
4.4 EMERGING THEMES 
 
One of the early findings from this study was the sensitivity around the formation of a definition and 
a sharp, sometimes abrupt discord amongst members of the executive board of NHS England when 
probed about their understanding of unwarranted variation and how the NHS should respond. That 
discord uncovered a sense of tension and an air of reluctance to even discuss the issue of variation, 
including at commissioning board level; although their comments offered a tacit expectation that 
this was a role for commissioners, using existing management and contracting processes. There 
appeared to be little cohesion amongst members to inspire any confidence that identifying and 
reducing unwarranted variation was an issue that they would address, with some even stating that 
the undertaking was “just too difficult”. This was a marked contrast to the response, during an 
informal conversation, with a very senior government official, who not only believed that the NHS 
should address unwarranted variation but that he expected the NHS to respond accordingly. 
 
A further set of semi-structured interviews was conducted to capture the views of a sample of key 
clinical members of the forming CCGs. The views expressed by those leading clinicians, when asked 
whether or not the NHS should address unwarranted variation, were remarkably different to those 
from the executive members of the NHS Commissioning Board. Most of the senior clinicians believed 
that the NHS should respond to this phenomenon and commented that they anticipated stronger 
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leadership, which included a definition of unwarranted variation from the Commissioning Board. It 
was interesting to note that some of the leading clinicians associated this phenomenon with the way 
the management of the NHS had behaved previously, creating a target culture, and claimed that the 
NHS Commissioning Board had no difficulty in telling them [GPs] what other targets to deliver and 
how to deliver them, for example waiting times or access to see a GP, for which a definition for 
measurement was created. It was therefore with puzzlement that the clinicians asked: why can’t 
they do it for unwarranted variation? 
 
The text below draws out the key themes established from the literature and interviews, which 
illustrate a yawning gap between members of the NHS Commissioning Board and the leading GPs on 
this issue: 
4.4.1 Key Theme – Definition 
 
“I think there should be a commonly-used definition of what warranted and unwarranted 
variation is. I think it’s quite difficult to do but I think it must be possible… I’ve put no effort 
into actually doing that but I do think it needs to be done.” [Executive member, NHS 
Commissioning Board] 
 
“I am opposed to the concept of defining variation… as there are different degrees for 
legitimate variations in different processes and outcomes…” [Executive member, NHS 
Commissioning Board] 
 
Those working in the service at the CCG offered a different view: 
 
“It would be very useful to have greater clarity on it… I find as I go round talking to people 
about variation, different people have very different understandings of what it is and which 
problems it’s going to solve and how it’s going to solve them, and what those solutions will 
look like.” [GP] 
 
“To use variation as a tool… is a valuable tool, it’s a really good prompt and I don’t know of 
any GP or clinician that does not respond to being an outlier when you look at variation.” 
[GP] 
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The dissent in the executive group echoes the literature where Thompson (2002) asks what the 
problem is with variation as it is inevitable a point reinforced by Neuhauser et al (2011) claiming that 
some variation is random and cannot be eliminated.  
 
4.4.2 Key Theme – Managerialism/professionalism 
 
The views of the GPs were less pointed when probed more deeply about the identification and 
measurement of unwarranted variation, rousing some animated discussions amongst the clinicians. 
These were related to the use of poor data to measure improvement, as demonstrated by the 
passages below: 
 
“We [GPs] have had some dreadful data used to measure our performance…” [GP] 
 
“It does depend who [provides the data] and how those data are provided…it’s an issue of 
trust and then ownership… one of the first reactions is that the data is not right; it’s a 
defence of our clinical practice.” [GP] 
 
“If you put performance data up, doctors being doctors will say the data’s faulty or my 
patients are different. Doctors will always try and justify that.” [GP] 
 
These remarks reiterate discoveries from the literature. Berwick (1991) warned of the need for 
sensitivity when using performance data with clinicians. Dawson et al (2010) confirms this point, 
claiming that the use of performance data did not contribute to the better management of variation. 
This is a view endorsed by Hibbard et al (2005), who claimed that the public reporting of the hospital 
“star-rating system” would actually fail to reduce variation, perhaps due to the manipulation of data 
to achieve targets (Bevan & Hood, 2006). 
 
4.4.3 Key Theme – Training 
 
One theme that captured a sense of harmony amongst all respondents was that the NHS needs to 
do more to understand the concept of variation better and that the NHS may need to review training 
at all levels to incorporate the concept of unwarranted variation within core professional 
development programmes. 
 
  32 
“Where doctors are trained I think makes a difference. I think the people who have been 
responsible for supervising them and training them make a difference.” [Executive member, 
NHS Commissioning Board] 
 
“I think you should go right back to the start of training to be quite honest. I think it’s 
medical training and for GPs it’s vocational training and specialist training for others.” [GP] 
 
“I think the profession has, at times, been incredibly arrogant in the past and still is to a 
fairly significant extent, in a way that actually doesn’t serve our patients well... clinicians 
think they’re doing the right thing… and therefore clinical variation is always somebody 
else’s fault or somebody else’s problem.” [GP] 
 
4.4.4 Key Theme – Reform 
 
The theme that captured most cohesion and energy and verbosity was the issue of reform and 
constant reorganisation, considered as being unnecessary changes, deflecting attention from those 
issues that really matter: patient care. The topic that was discussed the most was a perceived need 
to reform primary care, particularly as the implementation of the current reforms directed the 
majority of NHS funds through the new CCGs, with GPs sitting on the governing body. 
 
“The NHS has a long history of structuring itself and convening itself in a way that’s suitable 
to the people that work in the NHS rather than for the people receiving care.”[Executive 
member, NHS Commissioning Board] 
 
“I think it’s [the GP contract] a huge problem, I think it’s an absolutely huge problem 
because it goes from the sublime to the ridiculous… which kind of says ‘put your brass plate 
up and open your doors and you’ll get all this much money’… it needs reforming.” [Executive 
member, NHS Commissioning Board] 
 
“It’s the way that general practice has been funded and organised over the years, over 
many, many years… is rather on a bid culture basis, so inequalities and variations have 
arisen within practices.” [GP] 
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The themes above draw on the literature again, which confirms frequent reform (Klein, 2010; 
Hunter, 2012) and that clinical practice is one of the causes of unwarranted variation (Wennberg, 
2010) balanced with the knowledge that engaging professionals is considered an essential step to 
successful reform (Hurst, 2010). 
 
These themes captured in document 3 became constant and, supported by the literature, were 
conveyed into the next part of the study, a quantitative piece of research that helped to refine the 
conceptual framework. 
 
In summary, fresh material was elicited, which confirmed the themes and formed the research 
questions: 
 
 Does the NHS have a clear definition and classification of variation? 
 Is variation an issue for the NHS? 
 Is there a consensus on who should search for and address unwarranted variation? 
 Do individuals believe it is their role to reduce unwarranted variation? 
 Has training on the subject been made available and, if so, has it been of benefit? 
 
4.5 SUMMARY OF DOCUMENT 4 
 
Document 4, a quantitative study, is where the themes and concepts began to crystallise and where 
material and theories became more settled. Acknowledging that it would have been difficult and 
unmanageable given the size, complexity and nature of the NHS to seek a random sample of 
respondents from the 211 CCGs and 27 local area teams covering the English NHS, a strategy of 
convenience and judgemental sampling was adopted. This was justified as the cohort identified was 
restricted to those CCGs and area teams in the East Midlands, an area that represents approximately 
10% of the NHS, thus creating a representative sample from which inferences could be made about 
the NHS as a whole. 
 
The period of data collection was November 2012 to December 2012 and the instrument for the 
survey was an anonymised postal questionnaire, a method frequently adopted in health service 
research (Cook et al, 2009). Convenience sampling was used to identify subjects working in the 
newly formed CCG and area team within the geographical foot-print of the East Midlands. These 
new organisations were identified as being of meaningful importance and the natural next stage of 
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this study to capture wider and deeper contributions from the “field” in an attempt to improve 
representativeness and validity. The findings offered fresh discoveries that shaped the conceptual 
framework and are shared below, thus reiterating the key themes. 
  
4.5.1 Key Theme – Definition 
 
The classification or definition of variation has become another key theme. The majority of 
respondents from the small, geographical study responded that the NHS should investigate variation 
and also that the NHS should have a common definition. Interestingly, 52% of respondents claimed 
to already have their own working definition whilst others sought clarity by the provision of a 
definition. Of note, the contrary view, similar to that from the qualitative piece, is that some 
respondents believe that endorsing a definition would be unhelpful, judging that it may set 
parameters that constrain clinical practice. This was a concern of many when describing clinical 
guidelines, which became a key concept following this piece, supported by the literature. 
 
4.5.2 Key Theme – Dealing with variation 
The literature has confirmed that variation has been a conundrum for the NHS throughout its 
existence. The repeated exposure of variation led the researcher to identify how the NHS considered 
that it currently deals with variation. Subjects were given the choice of four statements to describe 
how they perceived the NHS currently does this, with the majority view being that the NHS tolerates 
variation. 
 
Figure 4 
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4.5.3 Key theme – Which organisation should identify variation? 
The response to this question from the limited geographical non-probabilistic sample frame began 
to crystallise the development of the main research question and sample frame. There was an 
overwhelming response to suggest that reducing variation was the role of the new commissioning 
organisations in the NHS, reiterating the inferred view of the executive members of the NHS 
Commissioning Board. 
 
The forming view is that the NHS perceives that tackling variation is too difficult, leaving the 
phenomenon to be unchallenged. What remains unclear is which organisation should lead this 
investigation and action and what are the views of commissioning and provider organisations. This 
deserved further exploration and formed the key line of inquiry for the main research question. 
 
Acknowledging that the study has introduced limitations by adopting non-probabilistic sampling, the 
next phase is to test these lines of inquiry across a wider geography. First, to understand the 
perspective of the providers, through semi structures interviews  and second to understand whether 
commissioning organisations are doing anything about reducing variation and for that a data source 
will be artefact analysis of commissioning organisation governing body papers, to confirm or deny 
that they are dealing with this issue. 
 
4.6  SUMMARY 
In summary, the analysis of the previous research (DaSilva, 2012b; 2013) established some common 
themes. These were mirrored by the literature and confirmed that the themes of study are like 
disconnected jigsaw pieces, illustrated below, with each piece holding a small part of the potential 
solution to resolve the problem of unwarranted variation. Blending the findings and literature as 
pieces of the puzzle has helped to shape the questions and conceptual framework for this study. For 
example, the qualitative piece offered markedly different views, some polarised at the extreme, 
about the need for a definition. This is an issue that remains unresolved alongside the appreciation 
of any preferred classification. Other evidence outlined the implicit expectation that it is the role of 
commissioning organisations to identify and reduce unwarranted variation; again this requires 
deeper investigation to understand the perception of provider organisations. The next step is to seek 
to answer those new questions which will follow the next chapter.  
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Chapter 5: Research aims and questions 
 
5.1 THE AIMS OF THE STUDY 
 
Thus far, the majority of the literature holds its focus on the identification and recording of variation 
(McPherson, 2008; Appleby et al, 2011; Mercuri & Gafni, 2011) and this thesis will reflect on that 
contribution. This study will, however, aim to take that important contribution one step further to 
understand what, if anything, can be done about reducing the observed variation by investigating 
some of the key themes, outlined in the previous chapter, with the main objective of establishing 
which organisation(s) should lead the search for and reduction of unwarranted variation. 
 
This thesis will build on previous research (DaSilva, 2012b; 2012c; 2013) and use the analysis of 
primary data to describe the implications for practice. To achieve this, the thesis needs to revisit the 
common themes and create a conceptual framework to help refine the line of inquiry and establish 
the questions to test. 
 
5.2 THE CONCEPTUAL FRAMEWORK 
 
The conceptual framework has developed through stages of thinking and reflection, evolving as the 
study progressed. It has set a framework for the study as an orderly arrangement of key themes and 
concepts to shape and simplify the research (Fisher, 2010), channelling the findings into a discussion 
(Miles & Huberman, 1994). It is acknowledged that, at the beginning of the study, the conceptual 
framework was, at best, embryonic and constructed as a simple collection and grouping of complex 
issues and topics (DaSilva, 2012b). It has evolved through reflective practice, extensive reading and 
discussion with peers. The conceptual framework has also been enhanced through the findings from 
earlier work (DaSilva, 2012c; 2013), to a puzzle, within a fragmented system where concepts are 
muddled and themes disarranged, moving to a more sophisticated alignment of concepts. 
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Figure 5  Conceptual Framework 
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5.3 AN EVOLVING FRAMEWORK 
 
The concept of variation in health care continues to puzzle commentators, many quickly flashing a 
light over the subject without fully exploring the topic (de Jong, 2012). This piece of research 
endeavoured to investigate the concept of variation using different lenses by applying qualitative 
and quantitative methods (DaSilva, 2012c; 2013) with the aim of understanding why it is an 
important issue for the NHS, how it can be addressed and what barriers are preventing action to 
reduce unwarranted variation. 
 
The research developed around a broad conceptual framework, incorporating two key theories. The 
first was built from the principles of creating the right argument (Toulmin, 2003), which offered a 
platform to articulate why the NHS should respond to reducing unwarranted variation. The second 
theory is the NHS as a complex adaptive system (Plsek, 2000), which gracefully balanced the 
emerging themes drawn from the literature (DaSilva, 2012b; 2013) offering a perspective why little 
or no action was taking place. 
 
The emerging themes which included the classification and lack of a clear definition of unwarranted 
variation, the unending programme of reform and reorganisation of the NHS with its implications 
and consequences (Fulop et al, 2005) built on the notion of market principles and the implications of 
the purchaser/provider split, the impact of clinical guidelines and the training needs of staff to be 
confident to search and identify unwarranted variation.  
 
5.4 FORMING THE RESEARCH QUESTIONS 
 
The earlier research (DaSilva, 2012b; 2012c; 2013) explored the topic of variation in health care 
using different methods and by filleting and distilling those findings, some meaningful themes have 
remained consistent. These have shaped the following research questions:  
 
 What are variations in healthcare and why are they important? 
 
 How should the problem of dealing with unwarranted variation be addressed? 
 
 What are the perceived barriers to the NHS responding to unwarranted variation? 
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 Chapter 6: Research approach 
 
6.1 INTRODUCTION 
 
This chapter will reveal the methods and instruments for data collection. It will justify why rejecting 
the single use of either a quantitative or qualitative method was made and why a mixed 
methodology was identified as the most appropriate way of gaining robust data for analysis to 
answer the research question. With the context and motives for this study declared in Chapter 2, 
this chapter will assert the philosophical stance, being careful not to waste too much time on the 
declaration and defence of a theoretical position at the expense of the study itself (Sandelowski, 
2000). 
 
6.2 RESEARCH PHILOSOPHY 
 
The genesis of the study was postulating that there may be a single answer to explain why 
unwarranted variation persists in the NHS. It had been considered that such an answer may be 
created by a better alignment of existing practices – for example, clinical training or management 
processes in the planning or contracting activities of the NHS.  
 
The starting point was from an assumed position of a realist, a perspective of positivism (Fisher, 
2010) where knowledge can – and can only – be gained by objective observation and measurement 
(Cameron & Price, 2009). This approach would generally consider using scientific methods, which 
would conform to using quantitative research methods. However, following periods of 
contemplation and on reflection it was considered that adopting a quantitative method alone may 
not answer the research questions. The same conclusion was drawn when considering a qualitative 
method only too, which is why a mixed methods approach was adopted; representing a marked 
development in scholarship and a new confidence in research methodology.  
 
The level of confidence was recognised as my own philosophical position began to form, built on the 
comfort that all measurement is fallible and through interpretation can be justified (Goldkuhl, 2012). 
This was, in part, triggered by an epiphany realising that all data and facts are like pebbles on a 
beach, waiting to be picked up and collected, looked at from time to time and measured to create 
knowledge (Arah et al, 2003). A second philosophical movement was the recognition that the study 
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may make a small, but nonetheless important, contribution to the topic under scrutiny; it was, after 
all, not going to be providing a single answer or a solution. 
 
This sophistication led to a declared ontological position as a realist acknowledging that adopting 
this stance, recognising that truths can be established in a social reality, introduces inherent dangers 
of ignoring bias by illuminating one’s own assumptions and describing what the researcher wants to 
see from the data and evidence, (Orb et al, 2000) rather than explaining what is actually being 
observed (Fisher, 2010). Furthermore, in declaring an ontological position as a realist it is a reminder 
that researcher’s need to be aware not proceed arbitrarily to consent to accept data and facts as 
presented, but to adopt a research methodology which will not abandon all objectivity and 
measurement (Cameron & Price, 2009).  
 
This maturity and personal growth provides sound evidence of a transformation and increasing 
comfort in reflective practice and to review material through different lenses, to seek and discover 
new knowledge. Indeed, the behaviour and response from leading clinicians, described in section 
1.4, was one of the reasons this study was conceived and undertaking the study has stimulated an 
greater appreciation of their reaction, although not their behaviour. This transformation in thinking 
was not a single event. It has occurred many times throughout this study; I have even stopped to ask 
myself whether variations really exist and whether the study is focused on the right topic! 
 
Furthermore, in declaring ones philosophical stance, it is important to retain an awareness of other 
paradigms and not to rely wholly on looking through the realist lens, but to constantly reflect and 
consider the ontological position and the position of other commentators and subjects participating 
in this study. This reflection is important when applying a mixed methodology, recalling that answers 
and concepts will have been constructed from the responding subjects’ own understanding of reality 
and their experience and understanding of the concept in question – in this case - variations in 
health care. 
 
In summary, the declaration of one’s own is philosophical position is important to appreciate and to 
reflect upon. I have made the bold assertion that I seek more comfort in adopting a stance of 
realism. My personal declaration should not, however, determine the whole study. This is a point 
made by Trochim (2006), who declares that researchers should check in on the philosophical debate 
from time to time and think about the assumptions we make about the world when we conduct 
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research. Nonetheless, in the meantime, we cannot wait for the philosophers to settle the matter. 
After all, we do have our own work to do! 
 
6.3 ETHICAL CONSIDERATIONS 
 
Ethical considerations are woven throughout any research and can be intimidating (Orb et al, 2000; 
Guillemin & Gillam, 2004). Although the ethical principles governing qualitative and quantitative 
research are essentially the same (Richards & Schwartz, 2002), there are a number of special ethical 
issues that arise in relation to research in health care (Merriam, 1998; Orb et al, 2000; Yin, 2009). It 
is vital, therefore, that researchers navigate an unsoiled course through their research study 
(O’Leary, 2009), remembering that those pieces of research that do not meet the high standards of 
ethics cannot be referred to as good research (Bowling, 2009). 
 
This warning necessitates that researchers remain alert at all times, remembering that the research 
study must be conducted with integrity, do no harm and adhere strictly to the ethical codes (Bryman 
& Bell, 2007). In this case, the ethical codes include those of Nottingham Trent University, the NHS 
Managers Code of Conduct and those of the professional body for nurses, the Nursing and 
Midwifery Council (NMC). It is important to remain alert to these codes as they may be updated and 
amended on occasion and could assist researchers by including a fast track or automatic approval 
process (Cameron & Price, 2009) when studies require the researcher to seek ethical approval 
(Moule & Hek, 2011). 
 
The NHS in England has a long history of producing and preserving ethical guidelines, overseen by 
local research committees (LREC). Research guidelines have mainly been in the area of clinical trials 
and medical research but are also there as governance for all other types of research. Whilst there 
to protect researchers and participants of research, particularly vulnerable groups, this governance 
system has been criticised as being too onerous and inconsistent (McDonach et al, 2009), with some 
offering solutions to speed up the process (Tod et al, 2002) and others suggesting that some 
research could be overseen by other research governance structures (Ashcroft et al, 2005). 
 
This research study found favour in obtaining approval through the National Research Ethics Service 
(NRES) and the Integrated Research Application System (IRAS). Regulations for research were 
amended in the NHS in April 2009 although some still say that those changes did not go far enough 
(Thompson & France, 2010). However, as the proposed study involved survey and interviewing staff 
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and reviewing public documents and no identifiable patient information from health records was to 
be used, confirmation was received that the study did not require full LREC approval. Therefore, the 
research study could proceed once university ethical approval had also been received. This was 
sought and granted at each stage of data collection with final approval granted in August 2013. 
However, the streamlining of research application process through the National Research Ethics 
Service (NRES) and the Integrated Research Application System (IRAS) was helpful but not an escape 
from retaining an awareness of the principles of good ethical research. The principles of good 
research were applied at each and every stage. To ensure and maintain high ethical standards, a 
clear process to collect the data was designed to assure the participants of their position in the 
study. For example, they had opportunities to withhold any information or withdraw from the study 
at any time. To illuminate this important point, the first set of data was to be collected through 
questionnaires for subjects identified using non-probabilistic sampling. A letter was forwarded to 
each individual to explain the context of the study and the expectations of their contribution. 
 
The same process was adopted for the collection of qualitative data, through semi-structured 
interviews. Each subject was copied a letter of invitation to join the study and offered an 
opportunity to ask any questions, prior to, during and following the interview. Each subject was also 
invited to sign a form, prior to any questions, to indicate that they understood the purpose of the 
interview, that it was a part of a research study, that they had received the briefing details to explain 
the research and that they could withdraw at any time of the study. The participants were also made 
explicitly aware that their signature gave permission for the interviews to be recorded, for 
transcribing at a later date and that they could be used in whole for the study. Again, they were 
reminded that at any time of their choosing the tape could be turned off and the contents 
destroyed. At the closure of each interview, each subject was invited to offer any additional 
information beyond the structured interview if they wished, before de-brief of the interview was 
completed, ensuring the participant was comfortable with all proceedings. 
 
6.4 RESEARCH METHODOLOGY 
 
This study is seeking to understand how the NHS can respond to the problem of variation and what 
barriers prevent action to reduce unwarranted variation. This is an issue that is becoming 
increasingly important during a period of austerity and rising demand and as the NHS seeks to 
reduce duplication and minimise waste, to release funding to invest in higher value care (Porter & 
Teisberg, 2006; Cheung & Gray, 2012). 
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It was not possible to engage the entire NHS and, acknowledging that selecting either of the two 
traditional methods may not yield the data necessary to answer the research question, a mixed 
methodology was identified as the best option. It is recognised that any data collection was unlikely 
to obtain a true representative “sample”, thus introducing limitations by fixing a magnetic block to 
the compass of scientific generalisability (Bryman & Bell, 2007) and transferability (Guba & Lincoln, 
1994). As a means of mitigation, the study would triangulate multiple sources of data to increase the 
reliability and validity (Van de Ven, 2007). These limitations are declared and placed up front to 
assist the reader balance the strengths of this study, which is seeking to understand a multifaceted 
phenomenon (variation in health care) within a complex organisation (the NHS in England). 
 
6.4.1 Applying a mixed methodology 
 
Clough & Nutbrown (2012) make the point that it is important to declare and justify the 
methodology, the steps to be taken and the methods to assure readers that the methodology can 
answer the research questions. The methodology selected was a “mixed methods” approach, which 
has come of age (Creswell, 2011) with recognition that research moves along a continuum (Creswell, 
2003) and that the choice between quantitative and qualitative research methods should be 
determined by nothing more than the research question (Marshall, 1996). 
 
A mixed methodology is further justified recalling that qualitative methods are concerned with the 
systematic collection, ordering, description and interpretation of textual data generated from talk, 
observation or documentation (Kitto et al, 2008; Gorman & Clayton, 2004; Yin, 2009). It is 
considered a more flexible method than quantitative research in that it emphasises discovering 
novel or unanticipated findings (Bryman, 1984). On the other hand, the deliberation was whether to 
adopt a quantitative method. This was not wholly rejected but was considered a weak method as it 
may offer narrow answers that may not yield adequate data to answer the questions. 
 
A principle was made which was not to dismiss or reject the importance of either of the two 
traditional methods as quantitative research needs to be complemented with observational and 
qualitative studies, which can gather preliminary data to inform the design of quantitative research 
in creative ways to answer research questions (Teddlie & Yu, 2007). Malterud (2001) agrees, we 
need to prevent methodological separatism and supremacy if the field of medical knowledge and 
the benefits of a qualitative approach to health care research are becoming increasingly recognised 
by both academics and clinicians. Grypdonck (2006) helps us further to appreciate that qualitative 
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research is important for providing the understanding that is necessary to apply findings from 
quantitative research properly and safely. 
 
Therefore, the justification is revealed for selecting a mixed methodology as it is considered fruitful 
in bringing the benefit of not restricting the study to a set paradigm and way of thinking (Plowright, 
2012). The adoption of the methodology is considered constructive and beneficial to this study, and 
is further justified on the following three points: 
 
 The first was that the study was undertaken over a relatively short period of time, with the 
researcher operating within the requirements of a supervised and formal course. Whilst this 
compressed any scope of designing an in-depth study using either the qualitative or quantitative 
method, the benefit is that the requirements of the course offered a greater insight and 
proficiency into the existing research methods, presenting greater enlightenment, opportunity 
and personal development. 
 
 Second, adopting a mixed methods approach does not dictate that the researcher holds a 
particular fixed philosophical position prior to beginning the research study (Plowright, 2012). 
Instead, the researcher retains an open mind to finding a solution to an important issue – in this 
case which organisation(s) should lead the response to reduce unwarranted variation. 
 
 
 The third point was based on the profound epiphany that the study was not likely to reveal a 
single answer, as postulated at the outset, nor was there to be any kind of set picture; it had to 
be an iterative process. This position required heightened reflexivity and an open mind to 
construct a methodology that was capable of capturing the evidence to be able to answer the 
research question. Furthermore, the selection of a mixed methodology, comprising data 
collection through sets of semi-structured interviews and a review of artefacts and text analysis, 
supplemented with quantitative data collected through surveys, offered greater scope for 
deeper triangulation and greater validity (Bryman & Bell, 2007). 
 
6.4.2 Research design 
 
This study was conducted over a five-year period, with all data collected from August 2010 to 
December 2013, with the final set of data collected following ethical approval in August 2013 and 
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concluded in December 2013. The illustration below reveals the process for data collection to build 
the evidence base to answer the research questions. A brief résumé of the study will be offered to 
demonstrate how it has been assembled, using the findings from Documents 3 and 4, shared in 
more detail in Chapter 4, to build the research question and methodology for this final piece of the 
study. The illustration below clarifies the sources of data collection for the whole study, culminating 
in Document 5, the thesis. 
 
Figure 6 – The sources of data for the study 
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6.4.3 Deciding the sample frame 
 
One of the eternal criticisms of research is that the sample size is often considered too small, with 
frequent disputes around the number of subjects required to allow a piece of research to be 
considered valid. Guest et al (2006) claim that having undertaken a comprehensive review of the 
literature, there is neither a fixed number, nor are there any fixed guidelines for determining sample 
sizes; it is a matter of judgement (Sandelowski, 2000). Maxwell (2008) describes the dilemma that 
whenever you have a choice about when and where to observe, whom to talk to or what 
information sources to focus on, you are faced with a sampling decision as, clearly, you cannot seek 
to interview everybody (Miles & Huberman, 1994) and may, therefore, need to go for convenience 
sampling (Buglear, 2005). Acknowledging those challenges and faced with the task of presenting this 
study as representative, a mixed method approach and convenience sampling (Marshall, 1996; 
Sandelowski, 2000; Bryman & Bell, 2007) was adopted to offer both breadth and depth to the study, 
complemented by triangulation of multiple sources of evidence. The data analysis triangulation 
applied in this study used multiple sets of data to illuminate and offer depth and density to the data 
(Price, 2006). It demonstrates construct validity (Yin, 2009) and increases reliability and validity (Van 
de Ven, 2007) as the diagram below illustrates: 
 
Figure 7 – Data triangulation using multiple sources of data 
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6.4.5 Data collection and sample frame 
 
The data collection process, for the final part of this five year study, embraced three proven 
techniques: they are surveys using anonymised questionnaires, which provide a quick method of 
collecting data to provide insights into individual and organisational practices (Baruch & Holtom, 
2008), a set of semi-structured interviews, widely used and practical (Cameron & Price, 2009), and a 
review of artefact text analysis, which offers precise and unobtrusive evidence (Yin, 2009). 
 
Acknowledging the small sample sizes throughout this study, it was important to use multiple sets of 
data to increase validity and to strengthen the study (Bryman, 2001; Bryman & Bell, 2007; Fisher, 
2010). Therefore, four sets of data were collected to offer ecological validity. The sample frame 
would be broadened to a national sample and three other sources of data collection: 
 
1. A national survey used a web-based tool (SurveyMonkey) to disseminate an anonymised 
questionnaire to the full membership of two national NHS organisations representing both 
commissioning and provider organisations of the NHS. The questionnaire was posted on two 
separate occasions, a month apart, with an email to the membership to invite them to 
participate at two weekly intervals. 
 
2. A random sample group of CCGs, for artefact analysis, was identified using the national list 
of the 211 authorised CCGs on the NHS England website and inviting a colleague to select 21 
random numbers between 1 and 211. Each number selected was then cross-referenced to 
the national list to identify that CCG. 
 
3. A sample of senior executives, working at board level positions, in an NHS provider 
organisation. Convenience sampling was used to ensure representation from a mixture of 
foundation trusts and non-foundation trusts as well as acute, mental health and community 
organisations. 
 
4. The final sample was a group of international “experts” working on the same topic (the 
investigation into unwarranted variation) in their own country. This group was identified 
through the membership list of the expert panel for the Organisation for Economic Co-
operation and Development (OECD) working group on medical practice variation and the 
Wennberg Collaborative (an international group of researchers studying this phenomenon). 
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Thus, four sets of data have been collected for this final piece to complement the data collected 
from previous research, the obligatory stages of the DBA (DaSilva, 2012b; 2012c; 2013), and the 
interpretation and review of each has played its part to fashion sources of evidence. 
 
 
6.5 SUMMARY 
 
This chapter has positioned how the research was planned and executed, including the sources of 
data, how those sources were carefully selected and the process for analysis. The study triangulated 
multiple sources of data to declare construct validity, offering a greater depth and breadth to the 
study. The data for this study has been prepared in the visual form of tabulation, formed from pivot 
tables where appropriate, to enable the reader to see results without distracting them with fanciful 
schemata. The presentation of other data will use the form of free text and quotations from the 
transcription of the interviews. The next chapter will present the findings and analysis. 
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Chapter 7: Findings and Analysis 
 
7.1 INTRODUCTION  
 
This chapter discloses the findings from the primary data collected from the four sources and will 
reveal how these findings are strengthened by the supporting literature and the combination of the 
findings from earlier research (DaSilva, 2012c; 2013) to build a robust evidence base to support the 
conclusions and recommendations for practice in Chapter 8. This chapter will share the findings from 
the analysis by following the questions (Section 1.1) as a line of inquiry. 
 
7.1.1 Sources of Evidence  
 
There are four sources of data for this document. First, there is a national survey which collected 
data via an anonymised questionnaire from the membership of two national NHS organisations, 
which yielded 242 responses. The anonymised survey did offer a representative, albeit small, sample 
of NHS staff which was acknowledged as a limitation to the overall study. Therefore, to strengthen 
the study, three further data sources were used (Figure 8) with the findings triangulated to offer a 
strong evidence base.  
 
 
Those four sources of data are illustrated below: 
 
 A national survey of two NHS membership organisations 
 A semi-structured telephone survey of NHS Providers.  
 Artefact Analysis from a random sample of CCG governing body papers 
 International survey of OECD countries 
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Figure 8 – Description of the sources of evidence for Document 5 
 
 
These sources of data will complement the data and findings captured in Documents 3 & 4 
(DaSilva 2012c; 2013) as illustrated in figure 6 - pg 46  
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7.1.2  Survey Demographics 
 
The first figure shows the demographics of respondents from the national survey. Analysis revealed 
that the 242 responses yielded responses from each of the four geographical and administrative 
regions of NHS England, confirming a good geographical spread of the NHS. Although it was not a 
true representative sample, it is considered sufficiently diverse to analyse and present the findings 
as evidence to answer the research questions.  
 
Figure 9: Region of respondents’ workplace 
 
 
 
Answer Options 
Response 
Percent 
Response Count 
North 36.4% 88 
Midlands & East 45.0% 109 
London 4.5% 11 
South 14.0% 34 
answered question 242 
skipped question 0 
 
The highest numbers of responses were from the two geographical regions covering the North of 
England and the Midlands and East region. This pattern of responses raises an interesting question, 
which would warrant its own research study: Is there an uneven spread of knowledge or interest in 
the topic of variation in health care, with a sharper focus towards the North of England creating a 
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North/South divide? Alternatively, is there a geographical divide in the observation of the incidence 
of variation across the NHS, with it being a bigger problem for the north of the country? 
The literature would contradict that assertion, with evidence to suggest that there is not a 
North/South divide; many studies (Reid et al, 1999; McPherson, 2008; Dodgion & Greenberg, 2009; 
McBride et al, 2010; Appleby et al, 2011; DH, 2010c; 2011) have confirmed the existence of variation 
in health care across the wide geography of NHS England. It is, therefore, reasonable to declare that 
it is not an issue restricted to any one part of the country. A possible cause for this pattern of 
response could be researcher bias, where the higher response rate has come from those areas 
where the researcher may have had an influence on those subjects responding to the survey. Again, 
that hypothesis would require a much deeper exploration and analysis to eliminate bias (Cameron & 
Price, 2009). However, the risk of bias was noted and the action taken to mitigate that risk was to 
use multiple sources of data, (Figure 8), and always to retain an open mind about the outcome of 
the research. 
The next question aimed to identify whether the respondents were a member of a Clinical 
commissioning group (CCG) or not. The NHS established 211 CCGs in April 2013 to take over the 
commissioning role of the Primary Care Trusts and some of the work of Strategic Health Authorities, 
which had been disestablished in the latest NHS organisational reforms as described in ‘Equity and 
Excellence – Liberating the NHS (DH 2010a).   
 
Figure 10: Membership of a Clinical Commissioning Group 
 
 
Are you a member of a Clinical Commissioning Group? 
Answer Options 
Response 
Percent 
Response Count 
Yes 45.2% 90 
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No 54.8% 109 
answered question 199 
skipped question 43 
The response reveals that 45% of respondents were a member of a CCG and 55% were not. This 
does not, however, offer a clear picture of the respondents, nor is it possible to assume that the 55% 
of respondents claiming not to be in a CCG were functioning in a provider organisation. The next 
question aimed to understand more of the role of respondents. 
 
It is acknowledged that the response to this next question did not yield a perfect representative 
sample of the NHS workforce, according to data from the health and social care information centre 
(www.hscic.gov.uk/workforce) but the survey did produce a good spread of professional groups 
which offers the study an acceptable blend and cross-section of the NHS workforce, as described in 
figure 11 below. 
 
Figure 11: Respondents main area of work 
 
 
Which of the following best describes your main area of work? 
Answer Options 
Response 
Percent 
Response Count 
Clinical 36.4% 88 
Policy 10.7% 26 
Management 50.8% 123 
Research 1.2% 3 
Academia 0.8% 2 
Other (please specify) 21 
answered question 242 
 
 
The highest response, 51%, claimed that the description “management” best described their role, 
followed by 36% of respondents selecting that the title “clinical” best described their role. A further 
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11% identified their role as being “policy” and 2% as, “research” or “academia”. There were another 
21 responses identified themselves as belonging to the category of “other”; which, on analysis 
appears to be more  related to a role description, not classification of role;  for example, Head of 
Performance, Prescribing Advisor or Development Officer Public Health. 
 
7.1.3 Triangulating the Data 
The study used multiple sources of data which were triangulated as a method of increasing the 
validity by mitigating the risk of bias and potential limitations of a small sample from the national 
survey, as introduced in section 6.4.3.  
 
The next data set was gathered through a semi-structured telephone survey of a NHS Providers. It 
was not possible, due to constraints of time and resource, to include all NHS providers in this study 
as the number of organisations reaches almost 300, even when excluding non-for-profit 
organisations and general practices. Therefore, a sampling method was adopted which sought to 
ensure that a mixture of provider types were included and for the sample to include at least one 
provider type from each of the main types of provider commonly found in the NHS. The sample was 
achieved using the technique of non-probalistic sampling to identify a number of individuals (n=10) 
working at a senior executive or board level position and furthermore, in a mixture of roles, as 
illustrated in Table 2. 
 
Table 2 – Characteristics of respondents and types of provider organisations 
 Provider type Role of respondent 
1 Hospital provider (FT) Director of Finance 
2 Hospital provider (FT) Chief Executive 
3 Community provider (non-FT) Director of Operations 
4 Mental health and community (FT) Director of Development and Strategy 
5 Hospital provider (FT) Director of Operations 
6 Hospital provider (non-FT) Director of Nursing, Quality and Service 
Improvement 
7 Mental health and learning disabilities 
partnership trust (FT) 
Director of Service Development 
8 Hospital provider (non-FT) Chief Executive 
9 Hospital provider (non-FT) Chief Operating Officer 
10 Hospital provider (FT) Director of Finance and Contracting 
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The third data set, complementing the national survey and telephone interviews, was sourced 
through artefact data analysis of publically available papers from the governing body of a random 
sample of authorised Clinical Commissioning Groups in England. Again, the justification for the 
random sample is a reflection of the constraints of time and resources, which prevented a collection 
of data from all 211 CCGs to cover the full geography of the NHS across England. Therefore, a 
random sample of 10% of CCGs was created. The method used to create this sample was to scan the 
NHS England website to extract the national list of the 211 authorised CCGs and then to randomly 
select 21 CCGs. Once the sample was identified a time frame was considered appropriate in which to 
make the search for evidence and a 6 month time period was created, justified as being the first 6 
months of CCG full authorisation as a public body; the period for the data search was April 1st 2014 
to 30th September 2014.  
 
The process to identify and separate those papers which were considered to be of interest and 
relevant to this study was through the use of the search terms, “variation” and “unwarranted 
variation”. A word search of each of the websites of the selected CCGs yielded a total of 903 papers 
for analysis. The next step was to eliminate any documents which had surfaced through the first 
search but could be considered outside the scope of this study, as the search terms applied to a 
management or governance control schedule. Table 3 (below) offers the detail of those documents 
available for review. 
 
Of the 903 papers available for review, there were 378 that had a reference to the search term 
“variation” or “unwarranted variation”. Closer scrutiny eliminated 148 of those documents  from the 
study as  the reference to ‘variation’ was linked to either a technical or a financial transaction for the 
purpose of executive governance processes (for example, “variations to standing financial 
instructions").  
 
Table 3 – Number of public governing body papers available for analysis from sample of CCGs 
Analysis Number of 
documents 
Total number of documents available from website search 903 
Documents that include a reference to search terms 378 
Number of documents eliminated as reference to search term was a 
technical definition/management process 
148 
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Number of papers available for analysis 230 
The remaining 230 documents were then coded and posted into a Board agenda heading (Figure 16). 
The final set of data was collected from an international cohort, considered valuable to set the 
context of the issue being studied and to illuminate the findings. The source of evidence for this data 
set was collected through a web-based survey of a number of OECD countries [n=20] to offer an 
international perspective on the topic of variation in health care. The countries selected were 
identified using the OECD website and the selection was made from those countries with a 
representative member of the OECD medical practice variation working group. A small sample of 
individuals from that group was then invited to participate in a follow up telephone survey.  
 
That international survey yielded a response from the following 17 countries: Australia, Canada, 
Czech Republic, Denmark, Finland, France, Germany, Italy, Korea, Kosovo, Netherlands, Norway, 
Portugal, South Africa, Spain, Switzerland and USA. Six respondents offered subsequently to 
participate in a small follow-up telephone survey. The countries participating in the telephone 
survey comprised Denmark, Finland, Germany, Netherlands, Norway and Spain. 
The findings from all sources of evidence will now be considered for analysis and presented, using 
the key research questions as a framework to guide the reader through the analysis. 
 
7.2 ANALYSIS 
 
The analysis from the questionnaire started with a validation of all of the returned questionnaires to 
ensure that they had been completed properly and that any that could not be used was rejected at 
this point. The information was then transferred from the website survey tool onto a Microsoft Excel 
spreadsheet, to allow for interrogation. Figures were then created to display the data for descriptive 
analysis. 
 
The purpose of interviewing is a sound method to gain information to understand the meanings 
people place on their experience, not to get answers, nor test a hypothesis (Seidman, 2006). 
Interviewing can, however, provide too much information (Cameron & Price, 2009) and researchers 
need to be careful not to lose the flow of information whilst trying to manage the interview. The 
interviews for this study were recorded and replayed several times before being manually coded, 
searching for patterns and themes of both supporting and contrasting comments. These were 
separated into a workable number of concepts (Saldaña, 2011), being aware of researcher bias 
(Bryman & Bell, 2007) and to code what is said not what is heard. 
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The data generated from the artefact text search was also coded using the search terms (variation, 
variations and unwarranted variation) and cross-referencing them against the title of the paper from 
the governing body agenda. The citations of the search terms were then entered onto a Microsoft 
Excel spreadsheet and data from the search were tabulated to provide a figure for analysis. 
 
This section will now disclose the findings from the analysis of the combined primary data to answer 
the research questions and will supplemented those data with evidence from previous research 
(DaSilva, 2012b; 2012c; 2013) and what the literature review generated. The section will begin with 
a reminder of the first question and the scale of the problem of variation and why it is imperative 
that the NHS responds. 
 
7.3 QUESTION 1 – WHAT ARE VARIATIONS IN HEALTHCARE AND WHY ARE THEY IMPORTANT? 
 
This section will reiterate why variation in health care is an important policy issue and that it remains 
a problem for the NHS. This section will reiterate why it is imperative that the NHS identifies and 
address unwarranted variation and will explore who should be dealing with that problem.  
 
A literature review (DaSilva, 2012b) has confirmed that variation; that is, the unexplained differences 
in the way care is provided from one area or hospital to another for the same condition or diagnosis, 
or a difference in the costs or access to care for the same or similar conditions is a ubiquitous 
problem for the NHS (DaSilva, 2012b). That problem spans the entire organisation (Dodgion & 
Greenberg, 2009) presenting a problem to the NHS and even though Hannan (1999) reminds us that 
unwarranted variation is the hallmark of poor quality care and DaSilva (2012a) reminds us that 
variation has been ever present in the NHS, it remains an unresolved puzzle. 
 
The literature also confirms that, since the seminal paper (Glover, 1938) identifying the presence of 
variation in health care, many articles have reconfirmed the existence of variation in health care 
across demographic groups, geographic areas, institutions and even within individual health care 
providers (McPherson et al, 1986; Ham, 1988; Berwick, 1991; Wennberg & Wennberg, 2003; de Jong 
et al, 2006; Appleby et al, 2011; Castelli et al, 2014).  
 
Whilst these studies continue to demonstrate the incidence of variation and many remind us of the 
importance of dealing with variation, there is a paucity of literature to declare how the NHS could, or 
should, respond to unwarranted variation, or who should take the lead. Of concern, is that on those 
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few occasions where action is proposed, they stop short of offering tangible solutions (White, 2011), 
and many evade the identification of the perceived barriers to action, thus maintaining an important 
focus on the topic but reiterating that unwarranted variation presents an unsolved puzzle, one 
which deserves greater exploration and understanding (Darzi, 2008).  
 
This position validates the importance of this study which aims to understand how the NHS should 
respond to variation, who should be dealing with variation and to appreciate what are the perceived 
barriers that prevent the NHS from doing so. The study is further validated by the perceived gap in 
the literature (DaSilva, 2012b) and the tacit assumption that the NHS will accept the recent national 
policy directive and respond by shining a light on variation, as declared in the NHS Mandate (DH, 
2013).  This medium may be a way of prompting the NHS to take action as it is the instrument used 
to hold the NHS accountable to the Secretary of State, as public guardian of the service, (Dixon & 
Ham, 2012) and for the period covering the years 2013-2015 objectives for the NHS commissioning 
board to include: 
 
 “reducing unjustified variation between hospitals in avoidable deaths, so that standards in all 
hospitals are closer to the best”(pg7) 
 “to shine a light on variation and unacceptable practice”(pg 13) 
 “Success will be measured not only by the average level of improvement but also by progress 
in reducing health inequalities and unjustified variation”(pg 27). 
 
The declaration of this ambitious policy is understandable, but it comes with its own health warning, 
particularly as the evidence has demonstrated a long track record of variation increasingly being 
observed in the NHS but with little evidence of action being taken to address variation (DaSilva, 
2012b). The policy initiative does not offer any clarity on “how” or “who” should reduce 
unwarranted variation and it is equally shy in defining which organisation(s) should lead the search 
for and reduction of unwarranted variation.  
 
That is a situation that required a better understanding which this study aimed to explore by first 
examining whether the NHS considers that variation should be addressed and if so, is it their role to 
do so?  
 
The national survey invited respondents to answer the following question: 
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Figure 12: Is variation an issue the NHS should address? 
 
 
 
Answer Options 
Response 
Percent 
Response Count 
Yes 99.6% 230 
No 0.4% 1 
Don't Know 0.0% 0 
answered question 231 
skipped question 11 
 
 
The responses suggest that there is a strong stated confirmation, 99.6% of respondents, that 
variation is a problem and one that should be addressed by the NHS. Interestingly, this response is 
remarkably similar to that gleaned from a more controlled survey, limited to the NHS organisations 
across the geography of the East Midlands, conducted 12 months previously (DaSilva, 2013). The 
findings from that survey revealed that 91% of respondents believed that the NHS should be taking 
action to identify and reduce unwarranted variation. 
 
This evidence that variation is a problem and one  that should be addressed is strengthened further 
by the responses which suggests that not only does 99% of respondents consider it important that 
the NHS addresses variation, but, the evidence in the next chart reveals that 90% think that 
addressing variation is a part of their role (Figure 13).  
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Figure 13: Is dealing with variation a part of your role 
 
 
 
Do you think that dealing with variations in health care is a part of your role? 
Answer Options 
Response 
Percent 
Response Count 
Definitely 90.1% 218 
Definitely Not 2.1% 5 
Had not considered it 6.2% 15 
Don't know 1.7% 4 
answered question 242 
skipped question 0 
 
 
These findings infer that the NHS considers the topic of variation as being important and one that 
should be addressed also inferring that the NHS accepts the policy directive described in the NHS 
Mandate. This perspective is further strengthened when we note that individuals also regard it a 
part of their role to do take action; a claim corroborated through the evidence of two previous sets 
of data yielded from an interpretive piece of ethnographic research (DaSilva, 2012c). The claim that 
variation is a problem for the NHS is emphasised further from the evidence from the verbatim text 
from three sets of semi-structured interviews; first a review of the comments from the executive 
members of the national NHS Commissioning Board, when asked: 
 
 “Do you think variation is an important issue for the NHS?” 
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“One of the great challenges ahead of us in terms of developing health care in a constrained 
financial environment is to tackle these [variations].” [Executive member, NHS 
Commissioning Board] 
 
“Yes, I have a view that there’s huge variation in health care across England. And it’s for a 
variety of reasons and we ought to be addressing it more than we are doing.” [Executive 
member, NHS Commissioning Board] 
 
“Dealing with variation has to be one of the top priorities of the NHS Commissioning Board… 
I think it should be absolutely mandatory. The challenge is how is that to happen without 
making it a contractual issue.” [Executive member, NHS Commissioning Board] 
 
 
 
Secondly, by analysing the responses from leading General medical practitioners (GPs) working at a 
national and regional level in a role to enhance clinical leadership in the planning and commissioning 
of care; they responded as follows: 
 
“Do you think variation is an important issue for the NHS?” 
 
 
“We need to decide how do we deal with variations and we do have to deal with it.” [GP] 
 
“I think it’s very clear that the issue of variation in health care is rising up the agenda, both 
at a level with the community, within general practices and at a national level.” [GP] 
 
“I think the NHS is relatively unsophisticated in it [NHS] may tolerate variation but if it does, 
then I have a sense that it tolerates variation because it’s easier to tolerate variation and put 
a lot of other stuff in tick-boxes than it is to provide a culture where ambiguity, variation and 
the understanding of that issue is acceptable.” [GP] 
 
Third, from the evidence collected during telephone interviews with senior executives working in 
provider organisations. When asked to reflect on the question, “Do you think variation is an 
important issue for the NHS?” 
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“The NHS has to respond to variation, its waste but it’s not that straight forward, we try to 
weed out unnecessary differences in the way we operate, and if they are variations to you, 
they are constantly being looked at.” [FT Finance Director] 
 
“Yes, we must challenge variation but only where it shows poor productivity.” [FT Director of 
Operations] 
 
“I think there’s a basic issue which hasn’t been thought through which is: What should our 
response to variation be?” [Non-FT Chief Operating Officer] 
 
 
7.3.1  Summary 
 
The answer to this first research question is clear; the NHS does consider variation as being a 
problem for the NHS and sufficiently important to warrant more action to identify and reduce 
unwarranted variation. The majority of staff NHS believes it is their role to investigate and address 
that variation, a perspective which is reinforced when combining the three sets of evidence together 
and corroborated further when blending these findings with the findings from the national survey. 
 
However, these claims are inconsistent with other evidence assembled from a review of the 
literature (DaSilva 2012b) which demonstrated that variation has been observed in the provision of 
care for more than 70 years (Glover, 1938) and that more variation continues to be recorded (DH 
2010c, 2011). It is puzzling, therefore, that whilst there is full endorsement of the importance of 
variation in the NHS and the acknowledgement that staff in the NHS believe it to be a part of their 
role, there does not appear to be much action to identify and reduce unwarranted variation. This 
perplexing position adds credence to this study and also warrants the introduction of the next 
section which is to understand how the problem of dealing with unwarranted variation should be 
addressed and who should do it? 
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7.4 QUESTION 2 – HOW SHOULD THE PROBLEM OF DEALING WITH UNWARRANTED 
VARIATION BE ADDRESSED? 
 
7.4.1 Who should respond? 
 
The previous section has confirmed the claim that the NHS does perceive variation is a problem for 
the NHS and is one which deserves to be addressed. Furthermore, there an overwhelming 
endorsement that individuals consider taking action to reduce variation is a part of their role. What 
remains unclear, however, is whether the individuals responding were doing so from a 
commissioner or a provider perspective (Figure 14) and this section investigated whether taking 
action to reduce unwarranted variation is considered a role for commissioning and/or provider 
organisations; a key theme of the study, as described in chapter 2.  
 
Chapter 2 has presented the policy background and supporting  literature to set the context of the 
separation of NHS organisations into either commissioning or provider organisations, as the NHS 
adopted quasi-market principles which were a result of  the reorganisation of the NHS in 1989, 
described in the white paper, “Working for Patients” (DH,1989). A core component of this study has 
been to understand who should deal with variation and in particular which organisation(s) should 
take action and how they should go about addressing the problem. As no literature could be found 
to enlighten us whether commissioning or provider organisations should lead the response to 
identify and reduce unwarranted variation, this study aimed to elicit new knowledge to understand 
whether that lack of clarity prevented action from being taken. A supplementary aim was 
established which was to distinguish how commissioning and provider organisations understand 
each other’s position of the topic and what they perceive are the barriers preventing action. 
The investigation sought to understand which organisation(s) the NHS thought should lead the 
search for unwarranted variation and used all four sources of evidence; the national survey, 
verbatim text from semi structured interviews, artefact data analysis and international survey.  
 
The findings are presented below starting with the findings from the national anonymised survey 
which used two NHS membership organisations as the sample. The survey was posted on the 
website of both membership organisations and as the questionnaire did not seek out to identify 
whether the respondent was from a provider or commissioning organisation it is not possible to 
separate out those responses:    
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Figure 14: National survey of NHS Membership Organisations 
 
 
 
Answer Options 
Response 
Percent 
Response Count 
Academic Health Science Networks 4.0% 9 
Clinical Commissioning Groups 37.2% 84 
Commissioning Support Organisations 3.1% 7 
Health & Well Being Boards 8.8% 20 
Local Authority 0.9% 2 
NHS England/Area Teams 23.9% 54 
Provider Organisations 2.2% 5 
Public Health England 10.2% 23 
Don't Know 2.2% 5 
Other (please specify) 7.5% 17 
answered question 226 
skipped question 16 
 
The findings offer an interesting perception, there is not an overwhelming vote for one organisation, 
although commissioning organisations (categorised in the table as CCGs and the NHS England 
Commissioning Board, through the Local Area Teams) do equate to more than 25% of overall 
responses. It is also interesting that the responses imply that it is not a role for provider 
organisations as shown in Figure 14, which reveals that only 2% of respondents to the national 
survey considered it a role for provider organisations.   
 
There is a sense of reasoning to that response, a line of logic which can be traced back to the 
inferred view from executive members of the commissioning board, where an argument is crafted to 
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support a claim that the search and reduction of unwarranted variation is a role for commissioning 
organisations, albeit, from the evidence, local organisations, not the national board! This claim is 
demonstrated in the tacit assumption, revealed during the interviews with members of the national 
commissioning board (DaSilva, 2012c), that local commissioning organisations, the new CCGs, ought 
to be the lead organisations to take any necessary action. The implication being that CCGs should 
deliver that challenge by using existing management and contracting processes through their 
identified provider organisations.  
 
Taking this superficial logic forward it can be alleged that CCGs could deliver this action through the 
application of their responsibility to set and manage contracts with provider organisations. Those 
contracts should have agreed specifications to which the commissioning organisations could hold 
providers to account for delivery; including the identification and reduction of unwarranted 
variation. Curiously, that implied management control was declared as being a process for CCGs, not 
necessarily the national commissioning board itself, who by inference appeared to absolve itself 
from any responsibility to addressing unwarranted variation, even in the parts of the service where 
the commissioning board is the lead commissioner, for example specialised commissioning.  
 
That logic is, however, considered as being too simplistic and probably based on the loose notion 
that the funds for the planning and procurement of services for a local population and the 
responsibility for ensuring services are available to meet the needs of that population rests with 
commissioning organisations, meaning it is they who should lead the response. The argument is 
clearly flawed if we recall the work of Plesk (2000) and his description of the NHS as a complex 
adaptive system where controls are diffuse and behaviours difficult to control and the logic is equally 
inconsistent with the observations of Jones & Wood (2010) and their declaration that commissioning 
is difficult within the NHS, made more difficult by the power retained by the provider organisations, 
some of them giants of the NHS.  It could be suggested that the assumed logic made by the 
members of the NHS commissioning board either chooses to ignore Plesk’s contribution of the NHS 
being a complex adaptive system, or that they simply choose to believe that there is a hierarchy 
within the commissioning structure with the national board sitting at the pinnacle of that structure, 
setting and directing policy, not implementing it themselves. This discrepancy in commissioning 
duties is illuminated neatly by the views of one of the executive members of the commissioning 
board who claimed: 
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These findings are most alarming; the national commissioning board do not appear to be taking any 
action to reduce unwarranted variation, consider it a role for the new CCGs and are not even 
thinking about addressing unwarranted variation. Yet, through the NHS Mandate, the executive 
board have declared that the NHS should place a spotlight on variation; leading to the next question, 
which attempted to clarify whether the NHS agrees with the notion that the reduction of 
unwarranted variation is a role for the new CCGs. 
This issue was examined through several data sources, starting with the national survey. 
 
Figure 15: Should CCGs lead the response to variation in health care? 
 
 
 
Answer Options 
Response 
Percent 
Response Count 
Yes 94.7% 180 
No 2.1% 4 
Don't Know 3.2% 6 
answered question 190 
skipped question 52 
 
“Have we ever consciously sat down and said these are the levers we’re going to use 
to reduce unwarranted variation or whatever? No, we haven’t! But they are 
potentially there… so we’re [NHS Commissioning Board] going to have to sit down 
and think about how we might do that. We’ve never done that before. I mean 
certainly we’ve never done in the past, just to think about how we can make that 
[align incentives] happen…. I’ve put no effort into doing it, by the way..” [Executive 
member, NHS Commissioning Board] 
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The response form the survey appears to be a compelling confirmation that addressing variation is 
considered a role for CCGs, underlining the inferred assumption from executive members of the 
commissioning board. This prompted the next line of inquiry which was to investigate whether there 
is any evidence of CCGs actually doing anything about reducing unwarranted variation and also what 
do provider organisations think of CCGs taking the lead.  
To answer that line of inquiry the study turned first to the findings from the artefact analysis of 
governing body board papers from the random sample of CCGs (Table 3). 
 
The sample had yielded 903 papers available for review and following a process of analysis and 
coding there were 378 documents that had a reference to the search term “variation” or 
“unwarranted variation” of which 230 documents were retained for the study. The 230 documents 
were then scrutinised to understand whether there was an equal distribution of observed recordings 
of the search terms across all those CCGs included in this study. That was proven not to be the case. 
The observed range of documents referring to the search terms, “variation” or “unwarranted 
variation” ranged from zero (n=12), to a CCG with 42 recordings.  
The 230 documents were then coded to be displayed against a set of board agenda headings to 
understand where those references could be found in the public governing body papers and a total 
of 370 instances were noted of the search terms as illustrated in the chart below.  
 
Figure 16: Observed recording of the term variation or unwarranted variation  
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The findings do reveal some important points. First that the topic is discussed in some, but only a 
few CCGs, with a small number of CCGs (n=4) accounting for the majority (51%) of the total recorded 
observations.  The topic could not be found on the agenda of any CCG but could be found on 
supporting documents, suggesting that the issue is not considered sufficiently important to warrant 
its own agenda item, regardless of the NHS Mandate declaration that the NHS should place a 
spotlight on variation. The second important observation is that the where the topic was making it 
to the governing body board of CCGs, the agenda headings to which the documents were directed at 
the meetings revealed that 92 of the 230 documents (40%), could be found in the section of the 
meeting relating to “performance and finance”. This is of concern on two counts.  
 
First, the analysis demonstrates that the topic is not on the agenda of CCGs and is, therefore, not 
reaching the “top table” of the CCG, which mirrors the position of the national commissioning board, 
thus leaving the topic unexplored. Second, where the topic is finding its way into the governing body 
papers, for the majority of the time, it is as a performance or finance issue; a position which 
reiterates the concerns of GPs that if the NHS was to address variation then it would become a 
performance issue for GPs, an issue uncovered in earlier research (DaSilva, 2012c) and illustrated 
below from the text from semi-structured interviews with GPs:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“I think that the danger we have in the NHS is that we don’t get performance 
managed on the [variation] data, I think we should be performance managed on 
how we respond to the data” 
 
“….my biggest fear is the Commissioning Board and CCGs will go into command 
and control” 
 
“I think many managers are frightened of this [variation] data and think it’s a 
performance thing” 
 
“There is a fear amongst GPs that the Commissioning Board is going to have a 
stick that it’s going to be … taking a sort of straight jacketed approach towards 
Primary Care.” 
 
“I would say is that as GPs, we’re aware of our variations and a lot of it boils 
down to we don’t really understand very well how to address it.”   
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The final statement effortlessly reminds us of the importance of this study and that the evidence 
establishes, that neither the terms variation, nor unwarranted variation, get much “air-time” or 
discussion at commissioning board or  CCG governing body meetings, but where it does get raised is 
favouring a performance management route, vindicating the concerns of GPs.  
 
This evidence is a fundamental concern; one which suggests that variation is going unchecked by 
commissioners, the implication being that neither the national nor local commissioning 
organisations are focused on this issue. This is in sharp contrast to the declaration from the earlier 
survey (Figure 12) that revealed 99% of respondents believe the NHS should respond to variation 
and that 90% believe it is their role to do so (Figure 13)! This confusing picture obliges further 
evidence, to appreciate what the provider organisations think, in particular about the observed 
recordings of the term variation from the artefact analysis (Figure 16) and the inferred logic from the 
national commissioning board that CCGs should lead the search for and reduction of unwarranted 
variation. To answer that line of inquiry the study now turns to the findings from the semi-structured 
telephone interviews from providers as described in Table 2. 
 
The findings from the semi-structured interviews with executives from provider organisations cast a 
worrying dark shadow over the issue of the NHS addressing variation. Plesk (2000) reminded us that 
the NHS is not a monolithic, command and control organisation, but is more akin to a complex 
adaptive system where the interaction between system agents is flexible. It would appear that this is 
none more the situation than in the relationship between provider and commissioning 
organisations. What became unmistakeably clear during the interviews was that when the 
executives from provider organisations were invited to comment on whether the lead role to 
identify and address unwarranted variation should sit with commissioning organisations, there was 
an unequivocal declaration that it should not, moreover that it is not a part of the commissioning 
role at all.  
 
Of more concern, however, were their endorsements that they considered it to be a role and a 
function for provider organisations – and were adamant that it is a role for provider organisations 
alone; even though, as stated earlier, providers have collectively maintained a degree of inertia and 
done nothing about addressing unwarranted variation for the past 40 years! These observations 
have exposed conflicting views about whether commissioning or provider organisations should take 
action to reduce unwarranted variation, an attitude which has created an unhelpful tension, but one 
which is probably not restricted to the topic of unwarranted variation. Indeed, the separation of 
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commissioners and providers and the lack of a coherent system of care appears to be a fundamental 
issue which should be addressed before the NHS can start taking action to identify and reduce 
unwarranted variation, as it appears from the observations below, that the two congregations have 
different strategic, regulatory and operational goals which appear to work against each other not as 
a system.   
 
This claim is evidenced by the responses from provider organisations with their responses suggesting 
that the task is definitely not something that any commissioning organisation to focus on, certainly 
not the CCGs, with the emphasis being that reducing unjustified variation is something for the 
provider organisations to deal with and provider organisations alone; their concern being that if 
commissioners get involved, the situation would only get worse! That evidence of discord about 
commissioners playing a part in the search for variation is displayed clearly by the comments from 
provider organisations when asked: “Who should lead the identification and reduction of 
unwarranted variation in the NHS?” 
“I would suggest that CCGs have enough other ‘stuff’ to get on with and that the lead on 
reducing variations is provider business.” [Director of Finance] 
 
“They [CCG] have got no fucking chance of dealing with variation now that public health has 
gone to the local authority, which is a great loss; they don’t have the capability or the 
resources or any fucking clue how to deal with variations, unless it’s in our costs.” [Chief 
Executive] 
 
“The CCG should get on and sort general practice out, that’s what they are there for… if they 
[CCG] would leave us [provider] alone to get on with what we are good at, we would all be 
better off. The CCGs aren’t there to tackle variations, but will have a go, like they have a go 
at everything else instead of sorting out GPs.” [Chief Operating Officer] 
 
“The new commissioning organisations are not fit for purpose to tackle such big picture 
stuff, they need to join up and work together… but that won’t happen, they will just fuck it 
up as always.” [Chief Finance Officer] 
 
“If CCGs were meant to do this kind of stuff, they would be called health authorities, with the 
resources and manpower to be effective, they are just too small.” [Director of Development 
and Strategy] 
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The statements clearly portray some very strong views about the ability and capacity of 
commissioning organisations to address unwarranted variation, but again, it may also be a reflection 
of what providers think about commissioning organisation in general, outside the remit of this study. 
What became clear, however, is that providers unanimously believe that variations will increase 
rather than reduce if the action to identify and reduce unwarranted variation is left solely with 
commissioning organisations.  
 
“No! CCGs should not be dealing with variations, it’s not their purpose. I think variation will 
increase, not reduce, with the new arrangements… we[providers] still have to treat what 
comes in through the front door whilst the 5 CCGs we contract with are all sorting out their 
own protocols and staff, there is bound to be more variations.” [Chief Executive] 
 
“I think it’s a quality issue, there are different commissioners expecting us to work to their 
different processes, variation is inevitable… there is no clear guidance how we should sort 
our patients out… it’s difficult, for patients and staff here.” [Director of Nursing and Quality] 
 
“… and it is impossible to have a proper conversation with CCG staff about these sorts of 
things… many are too junior and task orientated, it will only get worse.” [Director of 
Operations] 
 
These comments demonstrate a harsh contrast between the views of the providers, the response to 
the national survey and the tacit expectations of the NHS Commissioning Board, all revealing a 
striking dispute about which organisation should lead this challenging agenda. This situation may be, 
in part, a result of the frequent reforms, particularly of commissioning organisations which initiates 
an ever changing relationship between commissioning organisations and providers. 
 
One further possible explanation for this dispute is the constant pressure provider organisations feel 
under whilst commissioning organisations re-organise and change personnel. The flow of patients 
and associated activity does not appear to change when the NHS reorganises, yet the behaviour of 
the new commissioning organisations does as they seek to establish themselves as being “fit for 
purpose”; shifting their focus to higher strategic partnerships and plans sometimes at the expense of 
the provider organisations (Hughes et al, 2013). 
 
  73 
The churn of commissioning organisations through frequent re-organisations is well expressed in the 
following statements from executives working in provider organisations: 
 
“There is a huge difference in pace between the daily operational work and targets we are 
expected to hit and the pace that the CCG work at. I don’t think that the CCGs have got any 
idea about the numbers and types of patients we see. The A&E is a focus for them [CCG] and 
that is working to a maximum, they [CCG] forget about the wards, discharge processes and 
support teams so I don’t think they should be interested in dealing with variations in our 
trust.” [Chief Operating Officer] 
 
“If the same people would stick around, they would stand a chance but CCGs are light 
weight PCTs and have to work alongside GPs… and they will never agree on anything 
strategic… so it’s the merry-go-round of staff in commissioning that reduces your chance… 
sorry!” [Chief Executive] 
 
What has become clear is the striking difference of views between the providers and commissioning 
organisations about which should take the lead, perhaps due to differing strategic and operational 
obligations. Provider organisations clearly think it is their role to lead the identification and 
reduction of unwarranted variation yet they do not appear to be doing much about it. Conversely, it 
appears that commissioning organisations also consider it to be their role but are indecisive about 
doing so. Of more importance, however, is that neither appears to be taking any action to reduce 
unwarranted variation perhaps and little clarity about how they should go about it apart from the 
application of management tools such as the NHS standard contract as described above.    
 
This stimulated a line of inquiry to understand whether the NHS in England is alone on this matter 
and the next source of evidence from an international survey suggests the NHS is not alone. 
Acknowledging it is always difficult to make direct comparisons between countries as each has its 
own terminology; for example, the organisations we refer to as commissioners are often referred to 
as payers in many of the OECD countries. The aim of this survey though was to obtain a perspective 
from other countries to understand whether the NHS in England was alone in its pursuit of 
identifying and reducing unwarranted variation.  
 
Many of the OECD countries engaged in the study are faced with a similar dilemma of increasing 
incidence and awareness but little or no action to identify and reduce unwarranted variation. Even 
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when accounting for the fact that their health system was different and that they did not have the 
clear separation that the NHS has of payers (commissioners) and providers, respondents did offer an 
important insight into this area. 
 
“We have a central system with municipalities and nobody really knows what to do… I don’t 
know who should lead but we think of a conference with clinicians and politicians to organise 
a solution should happen.” [Denmark] 
 
“Our health [system] is not split like yours; there is a reform to have a purchaser and provider 
split but not now. I cannot pinpoint who should lead but think that ministers will tell the 
hospitals to do it.” [Finland] 
 
“We do not have a fixed programme to do this, we have lots of small pieces going on and the 
research centre [VPM Atlas/ECHO] does lead the focus for data but I don’t know what 
happens then.” [Spain] 
 
“First, it should be clinicians and national policy makers make it a job for the insurers but 
they don’t work in the clinics… they have to be encouraged to work together in a coherent 
way.” [Netherlands] 
 
“We have too many big hospitals and many beds with poor ambulatory services. The 
hospitals will not do it, we pay them too much and our GP system cannot change that… we 
have to learn from other countries.” [Norway] 
 
The evidence from the survey of OECD countries suggests a similar picture to that of the NHS in 
England: that the topic of variation remains an unsolved puzzle, one that many countries are trying 
to address. In many of these countries, there is not a clear purchaser/provider split, as described in 
the NHS in England, but there are organisations responsible for funding care and others responsible 
for providing care. It appears that in the six countries participating in the follow up telephone survey, 
neither their equivalent provider organisations nor commissioners (payers) are dealing effectively 
with identifying and reducing unwarranted variation and neither has the lead responsibility. 
The answer to who should lead remains unclear, an issue which will be discussed later in the section 
exploring the barriers to the NHS taking action, but next the study aimed to identify how the NHS 
should respond. 
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7.4.2 How should the NHS respond to variation? 
 
The evidence, thus far, has demonstrated that the NHS is not taking much action to identify and 
reduce unwarranted variation, regardless of the declaration in the NHS Mandate and the evidence 
that variation continues to be a problem for the NHS; as unwarranted variation is the hallmark of 
poor quality (Hannan, 1999) and a waste of valuable resources (Wennberg, 2010). Providers 
vehemently claim it to be their role, yet appear to be in a state of inertia about taking action and the 
commissioning organisations do not fare much better either; as the national commissioning board 
appear to absolve itself from either thinking about the issue or taking any necessary action with a 
conviction that it is the role for CCGs who in turn don’t appear to be taking much action and have 
difficulty finding space for the topic on their governing body agenda.  
 
So what needs to be put in place to enable the NHS to be in a stronger position to be able to 
respond? Throughout this study several common themes have surfaced and some of those themes 
will be explored in greater detail here. 
 
The literature (DaSilva, 2012b) suggests that the first challenge to encouraging the NHS to deal with 
the problem of unwarranted variation would perhaps be to raise the awareness and the profile of 
variation in the NHS, as described in the NHS Atlas of Variation series (DH, 2010c) and to create a 
cogent argument as to why the NHS should respond. DaSilva, (2013) cited the work of Stephen 
Toulmin and how his theory of creating a structured argument can offer a more cogent rationale for 
taking action to reduce unwarranted variation. This is considered essential if the NHS is to take 
action and reduce unwarranted variation and a brief overview of this model is presented below. 
 
Toulmin created a model to help articulate, justify and explain an argument by filleting and 
describing any argument as having four main components, each of equal importance and each 
requiring careful crafting to present a case of reasoning and a desired outcome. Those five 
components are based on the following components:  
 
 Claim,  
 Data,  
 Warrant  
 Backing   and  
 Rebuttal - visualised as: 
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Figure 17- Adaptation of Toulmin’s model argument 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
            
 
 
 
 
Adapted from: Toulmin, S. (1958). The Uses of Argument, Cambridge, England: Cambridge University Press 
 
 
As a model, this concept works by breaking the issue, in this case the identification and reduction of 
unwarranted variation, into clear inter-related categories which should stimulate the creator of the 
claim to progress to create a persuasive narrative, in this case as a rational argument to galvanise 
professionals into action. The warrant is the key to this model and will often be powerful enough to 
stand alone and be sufficiently clear. However, there are occasions, according to Toulmin, where the 
warrant is only broadly accepted and is met by a rebuttal which requires defending or ‘backing’ with 
a narrative to help the explanation of the warrant, in this case that the reduction of unwarranted 
variation releases resources to invest in higher value health care and reduces harm done to patients, 
or that reducing unwarranted variation reduces waste and duplication. Finally, it is important to note 
that Toulmin’s model does not create a fixed argument; rather it is a dynamic theoretical model 
CLAIM DATA 
WARRANT 
BACKING 
The NHS should reduce unwarranted 
variation in provision, uptake, costs and 
outcomes. 
Studies show that variation is ubiquitous in the 
NHS and unwarranted variation indicates low 
quality care. 
The NHS should shine a spotlight on variation 
[NHS Mandate} 
Reduce unwarranted variation in provision, 
uptake, costs and outcomes, so that outcomes 
across the NHS are closer to the best 
 
Rebuttal 
“We don’t trust the data” 
“Our Services are different” 
“There is no such thing as variation” 
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where the claim needs to be refreshed, the data renewed and the warrant re-framed to counter any 
rebuttals.  
 
The NHS Mandate (DH, 2013) has made a bold declaration, or ‘claim’, that the NHS should ‘shine a 
spotlight on variation’, but that claim alone, without justification through the creation of a coherent 
argument, is fundamentally flawed. The NHS has to move beyond the observation and recording of 
variation across demographic groups, geographic areas, institutions and even within individual 
health care providers as described previously, to one where action can be taken to identify and 
reduce unwarranted variation. That, it is argued, will require the construction of a better justification 
and purpose, backed with good data to warrant the claim that the NHS should take action to identify 
and reduce unwarranted variation, with a persuasive explanation of what needs to be done, by who, 
why and when and that complexity needs to be understood by all (Cohn, 2013).  
 
Regrettably, the findings thus far, suggest that the NHS has only part fulfilled the requirements of a 
coherent argument to stimulate the NHS to search for and reduce unwarranted variation; the claim 
has been made. The evidence obtained through this study makes it clear that the NHS is aware and 
alert to the incidence of variation, creating the unmistakable and that the NHS not only consider the 
issue to be important but that NHS staff consider it is their role to address variation, but do not 
know how to respond.  
 
A hypothesis can be developed to advocate that the awareness is shallow and any claim seeking the 
NHS to identify and reduce unwarranted variation is superficial, substantiated by the findings thus 
far and the literature. The Mandate has made the claim but it appears that neither commissioning 
nor provider organisations are responding. The next natural stage for this study is to explore what is 
preventing them from taking action and whether there are opportunities being missed.    
 
7.4.3 Could training help the NHS respond to variation? 
 
This study was seeking to understand whether the NHS considers that training and development 
should be provided to create a better understanding of the concept of variation and kick-start the 
NHS to systematically address the problem that variation poses. The recent reforms (DH, 2010a) 
have seen the creation of new organisations; Health Education England (HEE) and new agents in the 
recently formed Academic Health Science Networks (AHSN) both ideally positioned to heighten 
awareness and improve the opportunities of training and development around the concept of 
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variation. It is worth noting that in the national survey (Figure 14) only 4% consider AHSNs to be the 
organisation to lead this work and there is no first-hand evidence to suggest that either the AHSNs 
or HEE are picking up the baton.  The study has already identified that neither providers nor 
commissioners are taking the initiative so perhaps HEE and the AHSN should step into that vacuum, 
the alternative being that the current way that variation is going unchecked (DaSilva, 2013) will be 
prolonged, and the policy initiative to identify and reduce unwarranted variation will have failed 
even with the forceful recognition that the NHS needs to drive down unwarranted variations to meet 
patients’ changing needs, reduce harm and prevent the waste of valuable resources (NHSE 2014).   
 
Figure 18: Could training help the NHS reduce unwarranted variation 
 
 
 
Answer Options 
Response 
Percent 
Response Count 
Yes 86.4% 159 
No 1.6% 3 
Not Sure 9.2% 17 
Don't Know 2.7% 5 
answered question 184 
skipped question 58 
 
 
The response indicates unequivocal support that training and development should be made 
available. However, at first sight, the table indicates that 86% (n=184) declare that they think 
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training should be offered, this figure hides an interesting point, 24% (n=58) of respondents chose to 
skip this question, thus making it difficult to draw any real conclusion.  The response does imply that 
if the NHS is going to succeed in solving the puzzle presented by the concept of unwarranted 
variation, that a description of  “how” the NHS should respond may lie in closing the perceived gap 
in the training modules. This position substantiates earlier research, (DaSilva, 2012c) with 
undisputable, matching responses from members of the national commissioning board and leading 
GPs to suggest that the concept of understanding variation should become a core concept of 
professional development programmes. 
 
“Where doctors are trained I think makes a difference. I think the people who have been 
responsible for supervising them and training them make a difference, that’s where we 
should start.” [Executive member, NHS Commissioning Board] 
 
“I think you should go right back to the start of training to be quite honest. I think it’s 
medical training and for GPs it’s vocational training and specialist training for others.” [GP] 
 
The issue of training and development is clearly an issue for further research, and one that would 
need to be reviewed alongside other changes to the professional development of NHS staff including 
the availability of resources. On a positive note, Jewson et al (2014) suggest that the current period 
of austerity is not reducing the opportunity of training but that limited funds have to go further, 
implying that a development programme could be resourced. It is unclear whether training to 
increase the confidence and competence to explore and address unwarranted variation; an essential 
factor according to Mulley (2009) would find its way onto the curriculum.  
 
These findings support the literature which reveals a remarkable symmetry to this testament and 
the position of the NHS a decade ago. At that time Sipkoff (2003) displayed nine steps to describe 
how the NHS could reduce variation. Whilst he did not go as far as offering a clear definition, or 
stating who should lead, he did suggest that tools were available to enable the NHS to identify and 
reduce unwarranted variation. One tool, which has become a theme throughout this study, is the 
application of clinical guidelines. This introduced the question, could guidelines help to reduce 
unwarranted variation in health care?  
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7.4.4 Could guidelines help the NHS to reduce variation? 
 
The causes of variation were highlighted in Figure 2 where the supporting literature revealed that 
significant practice variation occurs where there is often a lack of clinical evidence. Some claim this 
situation could be resolved using clinical guidelines (Schwalm & Yusuf, 2011). The literature also 
showed that clinical guidelines are often employed as a means for reducing variation in health care 
and costs and for improving the quality of patient care (Rashidian et al, 2008) and are considered the 
most common initiative to reduce unwarranted variation in clinical practice (Cabana et al, 1999; 
Panella et al, 2003 Grimshaw et al, 2004).  However, the implementation of clinical guidelines 
remains a contentious issue (Kennedy et al, 2010) as they are often seen as an attempt to reduce the 
freedom of professionals and considered as a covert process to manage resources. The findings from 
this study strongly support the findings from the available literature; with more than half of the 
respondents (55%) claiming that clinical guidelines could contribute to the reduction of unwarranted 
variation whilst a third (31%) were unsure, and a further 11% claiming that guidelines would not 
help to reduce variation in health care as illustrated below: 
 
Figure 19: Could guidelines help the NHS reduce unwarranted variation 
 
 
 
Answer Options 
Response 
Percent 
Response Count 
Yes 55.2% 127 
No 11.3% 26 
Unsure 30.9% 71 
Don't Know 2.6% 6 
answered question 230 
skipped question 12 
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However, the devil is in the detail of how those guidelines are to be implemented across the NHS. 
This response raises an interesting point in that there appear to be positive views about the principle 
and intention of implementing guidelines but that interest is less positive when it comes to the 
application (Gupta et al, 1997) and uptake of guidelines (de Jong et al, 2010; Carlsen & Bringedal, 
2011). 
 
The responses from the telephone survey of OECD countries shed no more light on this subject, 
reminding us that when considering the use of guidelines as a method of addressing unwarranted 
variation that the NHS in England is not so very different to many countries: 
 
“We have the same problem… our doctors don’t follow procedure of guidelines always.” 
[Denmark] 
 
“There are times when we can use some help to make doctors follow guidelines but is not 
easy.” [Finland] 
 
“It is not our job to tell the doctors what to do, we provide the evidence and ask them to 
make ways to change it.” [Spain] 
 
“We know we have to make changes and the discussion is variation, most of the time we 
can make guidance, most of the time they ignore it.” [Norway] 
 
Interestingly, the interviews with peers from OECD countries raised another important issue, one 
which needed to be examined before this study can conclude, which is the language applied to this 
subject and the call for clearer definitions.  
 
Some of the OECD countries are just beginning to scratch the surface of the issue of variation whilst 
others have been exploring the concept for many years, as in England, and yet none appear to have 
a common and agreed classification or definition for their healthcare system, as illustrated by the 
text below: 
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“We need a vocabulary to explain what we mean and what we are doing; we need to 
distinguish between good and bad, including under and over treatments.” [Netherlands] 
 
“It’s not that clear… we use the term ‘unwarranted’ in our department but it is not the only 
word used.” [Spain] 
 
“Yes… there are many ways to describe variation and we have not bothered thinking about a 
[single] word.” [Germany] 
 
“We don’t think our country is looking for a word, we are trying to change resources and 
make a fairer system.” [Denmark] 
 
This issue is, of course, important when applying Toulmin’s theoretical model, as without a clear 
understanding of what is being claimed it will be difficult to craft a well-defined narrative and seek 
action; the alternative being that the argument will default with many more rebuttals and prolonged 
inertia. This study developed to understand whether the NHS has a common definition and whether 
one would help stimulate action. 
   
7.4.5 Would a common definition help? 
 
One of the key themes emerging throughout this study has been the disagreement about the need 
for a definition and classification of what constitutes unwarranted variation (DaSilva 2012b, 2012c, 
2013). The literature repeats this dilemma frequently stopping at the assertion that the concept of 
variation is multi-faceted, expressed as either ‘common cause variation’ which is random and which 
can never be eliminated (Neuhauser et al; 2011) or defined as ‘special cause variation’, that variation 
which is considered to be the result of external processes and one which management can take 
action to reduce; referred to as unwarranted variation (Wennberg, 2010). The mystification about 
the need for a definition is very much alive and is compounded by the multiple classifications found 
in  the literature, where the NHS frequently draws on classifications such as, “unintended” (Berwick, 
1991), “inappropriate” (Cabana et al, 1999), “unwarranted” (Mulley, 2009) and “unexplained” 
(Richards, 2009). This raises the question whether the NHS considers that the lack of a definition and 
clear classification is preventing the NHS from taking action to reduce unwarranted variation. 
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There was no specific literature found to help solve this part of the puzzle although, by implication, 
the literature, corroborated  by the findings from this study, do imply that there is not a consensus 
amongst NHS staff on either a definition or the need for a definition. Therefore, this study sought to 
add to the body of knowledge and understand whether the NHS considers it necessary to have, a 
definition of unwarranted variation. The data were collected through the national survey which 
asked whether the NHS needs a common definition to describe variation in healthcare. 
 
Figure 20: Does the NHS need a common definition 
 
 
Answer Options 
Response 
Percent 
Response Count 
Yes 77.9% 180 
No 13.9% 32 
Don't Know 8.2% 19 
answered question 231 
skipped question 11 
 
It is clear from the evidence, illustrated in the Figure 20, that the NHS considers that a definition 
should be developed with a 78% (n=180) response rate from the national survey, a declaration which 
practically replicates the findings from a previous smaller geographical survey, undertaken 12 
months previously, where 75% of respondents considered that the NHS does require a clear 
definition (DaSilva, 2013). From that evidence it would be simple to accept these findings and push 
the NHS to come up with a definition. However, that assertion hides some interesting issues and 
conflicting views, issues that have remained hidden and silent until now which need to be shared to 
help put this issue in perspective before any conclusions can be drawn.  
 
Whilst the evidence makes a case for a definition to be drafted, the findings from the interviews with 
executive members of the national commissioning board exposes a serious level of conflict amongst 
members and some polarised views on the issue of whether first, there should be a definition and 
secondly who should create one, as illustrated by the comments below: 
 
  84 
“I am intrinsically opposed to the concept of defining variation… as there are different 
degrees for legitimate variations in different processes and outcomes.” [Executive member, 
NHS Commissioning Board] 
 
“I think there should be a commonly-used definition of what warranted and unwarranted 
variation is. I think it’s quite difficult to do but I think it must be possible… [Executive 
member, NHS Commissioning Board] 
 
“I think we do need a more clear definition.” [Executive member, NHS Commissioning 
Board] 
 
These statements offer a sharp contrast to the findings of the national survey, and it would appear 
that whilst some of the executive members of the national commissioning board concur with the 
response to the survey, there are deep and contrasting views within the NHS Commissioning Board. 
One clear example and potential barrier to the NHS responding to the call to reduce unwarranted 
variation is a perceived lack of leadership from the national board, exposed earlier that the role to 
reduce variation is for local, not national commissioners and compounded by the claims that the 
leadership for this would not be coming from the “top team”; perhaps, being objective, that decision 
may be on the understanding that many of the policies for reducing variation only work at the level 
of the individual clinician, not national policy (Love, 2013). 
 
This conundrum about the crafting of a definition is not restricted to the NHS in England.  
The evidence, to this point, has exposed a potential barrier which prevents the NHS systematically 
addressing unwarranted variation. On the one hand, the evidence has confirmed that the NHS would 
favour a definition and that may be a good starting point to creating a cogent argument to explain 
why and how the NHS should address unwarranted variation.  On the other hand, the discord 
revealed from members of the national commissioning board suggests that the creation of a 
definition will not be coming from there. 
 
Again, remaining unprejudiced, it may be that the commissioning board appreciates that the 
development of a definition is going to require a well-articulated rationale for doing so and some 
sensitive moderation of different groups, a point which reiterates the claim by Bojakowski (2010) 
who stated that any definition should be done by consensus. Perhaps the next stage of investigation 
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for that consensus building is to appreciate what classification might be used to start that consensus 
building. 
 
Reflecting on the responses above and with a subsequent review of the literature a record was made 
of the multiple classifications and interchangeable terms applied in the literature. This study sought 
to understand whether there was a favoured classification across the NHS. The first step was to 
identify the five most common classifications within the literature and apply that ‘top 5’ to create a 
question to help explore which classification, if any, gains favour with the NHS.  
 
Figure 21: Does the NHS have a preferred classification 
 
 
 
Answer Options 
Response 
Percent 
Response Count 
Unwarranted 29.4% 68 
Unjustified 14.3% 33 
Inappropriate 10.8% 25 
Unexplained 13.9% 32 
Unacceptable 20.3% 47 
None of these 11.3% 26 
answered question 231 
skipped question 11 
 
The survey generated a mixed response, with no one classification coming out as a clear favourite.  
The rationale for this position maybe found in the earlier findings that there is an awareness of 
variation as a topic but that it remains a nebulous concept, one which has not received much 
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attention and a policy area which is under-developed which itself may be one of the main barriers to 
explain why the puzzle of unwarranted variation remains unsolved. These findings also suggest that 
there is a lack of leadership and no consensus from the “centre”, creating an air of confusion across 
the NHS; building a culture of dissonance and inertia around the concept of variation.    
 
7.4.6  Summary 
 
Thus far, the evidence has demonstrated that the NHS believes that variation should be addressed; 
the majority of the workforce believes it is a part of their role and although there has been a 
declaration through the medium of the NHS Mandate that the NHS should shine a light on variation, 
little has been constructed beyond that claim. There is a lack of a coherent argument, constructed in 
a way that is understandable to the NHS workforce as to why the NHS should bother searching for 
unwarranted variation. The NHS has declared that it would find a definition helpful but that is met 
with an ambiguous and conflicting response from the national commissioning board, which imply 
that they acknowledge that the topic is important but have done nothing about it. To be clear, there 
is no intention from the executive members of the national commissioning board to lead the 
discussions or to create a definition, something the NHS has declared it would find useful. This 
conveys an air of inertia, rather than a curiosity to act, which Mulley (2009) suggests is the way 
forward if health systems are to address variation. 
 
A considerable number of respondents do, however, imply a degree of curiosity and consider that 
training should be made available to help the NHS better understand the concept of variation. That 
claim would suggest that there is an ambition to address variation, but that organisations do not 
know how, or where to start the search for unwarranted variation. There is also a call from the NHS 
for a clearer definition for variation and description of unwarranted variation, a call which is 
receiving no attention from the national leadership team or any other sections of the NHS. 
   
These perceived barriers are preventing the NHS from responding to the call that the NHS should 
reduce unwarranted variation in provision, uptake, costs and outcomes are many levels. Some are at 
a strategic, national policy level; for example, the retention of the separation of commissioning and 
providing and the sustained use of quasi-market principles with differing objectives and perverse 
incentives creating a tension for the system to pull together to identify and reduce unwarranted 
variation. Other barriers at strategic level are exhibited by the constant reforms, particularly of 
commissioning organisations. There are other barriers at a behavioural level, demonstrated by an 
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absence of leadership on the topic at the national board, and the technical level, illustrated by the 
lack of effort to first sit down and consider what the NHS should do about variation, including 
looking at the incentives and drivers available and second, a lack of acknowledgment that, as 
national commissioners, they should be leading that work on the areas that they hold responsibility, 
and  leading the work to craft a cogent argument and definition for the NHS to respond to. There are 
further barriers in place at the operational level of the NHS where clinicians and managers fail to see 
eye-to-eye over incentives and targets and where there is a lack of management grip over the topic 
evidenced by CCGs failure to find a place for the topic on their governing board agendas and 
provider organisations making dull and hollow claims that it is a role for providers but do nothing 
about it.   
 
This paints a sorry picture and the only salvation is that the NHS in England is not alone; many OECD 
countries are facing the same challenge; some are at the beginning of that journey whilst others 
declare that they have been studying variation for many years, but equally have not moved on to 
formulate a cohesive and rational argument as to why it is imperative that the health system take 
action to identify and reduce unwarranted variation and removes those barriers which prevent 
action. 
 
7.5 QUESTION 3 – WHAT ARE THE PERCEIVED BARRIERS TO THE NHS RESPONDING TO 
UNWARRANTED VARIATION? 
 
Thus far, the study has used the evidence and supporting literature to answer the first two 
questions, both of which have highlighted several potential barriers to explain why the NHS may not 
be taking action to identify and reduce unwarranted variation. What has become clear from the 
evidence that there is not one single barrier to action, there is a cocktail of strategic, operational, 
behavioural and technical barriers, confirming Knickman’s (2004) claim. 
 
Figure 22 –Perceived Barriers to Action  
 
 
 
 
 
 
Technical Behavioural 
Strategic 
Organisational 
  88 
7.5.1 Strategic Barrier 
An unambiguous barrier is the absence of a clear and coherent argument to justify and explain why 
the NHS should be taking action to reduce unwarranted variation. Thus far, the rationale for action 
has been conveyed using the blunt instrument of policy. The issue of a crafting a cogent argument 
has been discussed previously, where Bojakowski, (2010) suggests it must be done by consensus and 
in section 7.4.2 there is a proposal that Toulmin’s theoretical model offers a helpful framework to 
assist in the construction of a sound narrative for action. To improve on that we can combine 
Toulmin’s theoretical model with other models, starting with the eight steps of successful change 
described below by Hurst (2010).  
 
The Department of Health, politicians and national leaders will need to make a fundamental step-
change in the way they communicate strategic expectations, as no strategy can sail freely across the 
under-current of culture, or as Davies (2002) concluded ‘Culture eats strategy for breakfast every 
day every time’. Davies (2002) also warns that the NHS is intensely tribal and to align both strategy 
and culture, which according to Stanford et al, (2012) is needed to improve patient outcomes may 
be a barrier too far. Morgan and Liker, (2006) remind us that an organisations culture defines what 
goes on in its workplace, a point not lost on Schien (2004) who suggests organisational culture is the 
way workers learn to solve daily problems and external tasks and neglecting the issue of culture, 
when setting strategy, is side-stepping a sizeable barrier to success. 
 
A second strategic barrier to emerge from the findings is the relentless attachment of successive 
governments to using market principles as a process of reform, demonstrated by the separation of 
commissioning and providing, with varying degrees of regulation and performance management. 
This study has revealed a sense of mistrust between the two congregations, leading to inertia about 
taking action to reduce unwarranted variation.   
 
Two change models could help here. The first is to aid the strategic intent (Hurst, 2010) and the 
second, perhaps more useful to assist organisations implement the policy, are the eight steps 
defined in Kotter’s model of change management (Kotter, 1996). 
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Table 4 – Effective ways to realise policy reform (Hurst 2010)  
 
The role of the professional monopolists who provide health services 
Communication and engagement – a rational argument for change 
A clear diagnosis and a compelling design for a reform 
The role of information and evidence 
Use of incentives, to align the interests of stakeholders 
The role of international comparisons of health system performance 
Taking advantage of political “windows of opportunity” 
Securing sufficient resources to “oil the wheels of change” 
 
 
Reviewing Hurst’s eight ways to reform reveals a yawning gap between the ambition of policy 
makers to reduce unwarranted variation and the reality identified from the findings in this study. 
The call to reduce unwarranted variation was communicated via the NHS Mandate (DH, 2013) and 
the likelihood of it being a success is severely restricted based on the literature and findings from 
this study. There is no evidence to indicate that any one of the above has been followed or even 
considered. Indeed, it could be effortlessly claimed that each has been ignored. If the NHS is to take 
the identification and reduction of unwarranted variation seriously, these eight ways to reform need 
to be followed assiduously from the strategy makers, which can be strengthened by NHS 
organisations applying Kotter’s eight step change model.  
 
7.5.2 Organisational Barrier 
 
The risk presented by organisational culture does not evaporate as the policy moves through the 
NHS; indeed it exists at several levels (Schien, 2004) and local culture may cause more resistance to 
the policy objective and become a bigger barrier. Organisational culture encompasses the taken-for-
granted values, assumptions, language and definitions of an organisation (Cameron and Quinn, 
2005) each of which must be confronted when implementing change. According to Appelbaum et al 
(2012) Kotter’s model offers an agreeable process to prepare organisational change, albeit with a 
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few limitations, including a challenge to Kotter’s claim that the eight steps should be followed in 
sequence; something the NHS may not be able to observe as  health care moves at a rapid pace 
(Spahr, 2005).  
 
Table 5 - Kotter’s eight steps to change: Adapted from Appelbaum et al (2012) 
 
1. Establish a sense of urgency about the need to achieve 
change 2. Create a powerful coalition 
3. Develop a vision and strategy 
4. Communicate the change vision 
5. Empower action 
6. Generate some quick wins 
7. Consolidate gains and produce more change  
8. Secure new approaches in the corporate culture  
 
 
Appelbaum et al (2012) conclude with a warning that following these eight steps does not guarantee 
success but disregarding one or more may mean that changes achieved through hard work and 
effort soon dissolve as the culture of the organisation thrives and people revert to the old and 
comfortable ways of doing things.  
 
There is an agreeable synergy between the above two models of change, which draw together the 
steps which can help to eliminate barriers to action at both strategic and organisational levels. 
However, the barriers identified through this study are extended beyond strategic and 
organisational to include behavioural and technical barriers, compounded by the retention of 
competition through market principles and the fractured health care system. 
 
 
 
 
  91 
 7.5.3 Behavioural Barrier 
 
The above sections have highlighted the challenge of culture and how it can disrupt the effective 
implementation of national policy. Acknowledging that, a common barrier to success is the powerful 
monopoly held by both clinicians and providers in the NHS (Hurst, 2010). This issue has formed a 
tormenting thread which has woven itself throughout the study. First, the power and influence of 
clinicians and their dynamic relationship with managers, discussed previously in section 2.8, needs to 
be rebalanced.  This study has reiterated that the long-standing tension between the clinicians and 
managers about ‘who is in charge’, which group should define service specifications, who should 
define unwarranted and who is responsible for the use of resources. This tension is not helped by 
the levels of bureaucracy, compounded by multiple layers of decision making at both clinical and 
management level, created by successive governments, which is now declared unfit for purpose, 
(Williams et al, 2007). It is argued that if the NHS is to take action to reduce unwarranted variation 
that there needs to be a united approach between clinicians and managers, at national and local 
level, with a clearly stated improvement methodology, using language and definitions which both 
parties can agree to, with accepted monitoring processes set against an agreed criteria.   
 
One method of achieving that would be to mitigate another perceived barrier which is the lack of 
training and development on the topic. Action should be taken to include the concept of variation on 
all basic professional training programmes and to drive forward with the dis-continuation of uni-
professional training. The NHS has long held an ambition to reduce uni-professional training and 
introduce more multi-professional training, where clinicians from all professions and managers are 
trained together (Blencowe et al, 2011). There is some hope that this ambition may come to fruition 
as the new organisations, Health Education England (HEE) and the Academic Health Science 
Networks (AHSN) can focus on multi-discipline and joint-professional training as these present a 
unique opportunity to align education, clinical research, innovation and training and education to 
improve patient care (Lipley, 2014).  
  
The evidence from this study would suggest that training and development is not only required but 
the evidence has demonstrated that there is an appeal from the NHS for training and development 
to be made available and therefore should be considered as a priority for the NHS.  A suggested 
model is presented below, ideally with clinicians and managers learning together within the ‘centre 
of variation in health care’ to understand and appreciate the strengths each discipline brings to solve 
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this puzzle. It is proposed that this training should be a fundamental part of all professional 
development and core training programmes.  
 
 
Figure 23 – Suggested framework to mitigate barrier of training/development 
 
 
 
 
However, that will not be sufficient in isolation, but could be a positive step forward as a method of 
contributing to the mitigation of another significant barrier, which has also been highlighted earlier; 
that is the marked contrast of views between the two congregations of the NHS - Commissioners 
and Providers; compounded by a bleak discrepancy in the expected behaviours of national and local 
commissioning organisations. Chapter 2 has described how successive governments have used 
market principles to reform the NHS and have retained the separation of the NHS into two 
congregations commissioning or providing through many reforms (Black, 2010).  
 
The contrasting behaviours and views of the commissioning and provider organisations has been 
described in detail previously, where it is contested that the case for local commissioning 
organisations to take action has no coherent explanation, only superficial logic and is lacking a key 
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step proposed by Hurst (2010) that there is no incentive for commissioning organisations to lead this 
work. It is suggested that gap needs to be addressed urgently and would probably require the 
manipulation of some technical barriers. 
 
7.5.4 Technical Barrier 
 
 Some of the technical barriers are probably unforeseen consequences of both strategic and 
organisational initiatives, for example, the national budget setting process and the business rules 
about savings and the need to deliver a year-end balanced budget set against a three year 
operational plan. These often prevent the NHS from constructing long term plans and reform of 
clinical pathways which take time to deliver. There are other national barriers which are the 
consequence of inconsistent regulatory processes for commissioning organisations, through the 
national commissioning board and for providers, through Monitor and the Trust Development 
Authority. It is proposed that there should be one set of regulatory processes, operating across the 
population, not organisationally determined and that those regulations are made transparent and 
the outcomes are publically available through a declaration of a shared responsibility of NHS 
organisations covering a defined population. The first step to this solution would be a better 
alignment of national policy, levers and incentives through a concordat between the national bodies 
responsible for health care.  
 
The latest NHS reform has presented the opportunity for this to happen as a new set of 
arrangements are now in place. It is considered essential that each of these organisations publically 
declare their line of accountability and responsibility, and share their action plan to co-operate and 
work within their health care system to identify and reduce unwarranted variation. It is also 
suggested that the Department of Health, as the organisation that holds ultimate responsibility for 
the health care system in England, and the organisation to which the national organisations are 
accountable, should co-ordinate this work and start by crafting a concordat between those 
organisations. 
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Figure 24 – Organisations that should be held accountable to each other for identifying and 
reducing unwarranted variation 
 
 
It is clear that neither the national, nor the local commissioning organisations, nor providers have 
made much progress in this arena, nor is there is a consensus on which organisation should lead, just 
inertia, mistrust and disharmony. It is postulated that this position is deepened as the organisations 
operate within a complex adaptive system, intensified as they are directly embroiled in a highly 
politicised system.  
 
The concordat is a method to release some of that political pressure as the health system defines 
and defends its approach to reducing unwarranted variation in a collective response which must 
therefore, be more than a signature of intent. As each of the organisations declares their line of 
accountability and responsibility they should also declare how they plan to work with the 
organisations accountable to them, publically stating incentives and penalties. It is acknowledged 
that policy makers and planners do not, perhaps, always follow the epidemiology and evidence of 
variation but do follow performance ratings and national standards and the concordat could 
function at both the extrinsic, for example, the reputation and benchmarking of the organisation and 
at the intrinsic level, for example, having a direct impact on the payment structure for executives 
and incentives for Board members.   The concordat could also be the instrument used to bring local 
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organisations together to work as a system, rather than independently, with local accountability 
through a local concordat, being careful that the bureaucracy does not become the driving force to 
make variation worse!   
 
The establishment of a concordat to promote systems thinking, rather than organisational survival 
and clinical dominance may also develop opportunities to eliminate one of the more difficult 
barriers, the powerful resistance from provider organisations who, this study has confirmed, are 
overtly hostile to the notion that commissioning organisations should be involved in reducing 
unwarranted variation. There is evidence of a toxic relationship, from providers, with very little trust 
or confidence in the capability of commissioners to meet the challenge to reduce unwarranted 
variation on trust, with an unequivocal claim that variation will increase, not reduce, if it is left to 
commissioning organisations.  
 
7.6 Summary 
 
This study has demonstrated that the barriers to taking action to reduce unwarranted variation are a 
mixture of strategic, organisational, behavioural and technical. The NHS needs to assess each of the 
barriers and clarify if one of the barriers is an unforeseen consequence of other policy initiatives, 
levers or incentives. It is clear that policy makers need to align policies to support the two main 
congregations, commissioners and providers, cast their differences aside and pull together to solve 
the puzzle presented by variation in the uptake, provision and costs of health care. New models of 
care should be designed which enable the system to operate together for the population they serve, 
not the organisation they administer. That may require some substantial modifications to NHS 
business rules and the generation of longer term relationships (Lewis et al, 2010). The worry though 
is that history has told us that the NHS suffers from frequent reorganisation (Hunter, 2012) and the 
way the NHS makes changes is not usually by subtle amendments to business rules but by significant 
and often top-down reorganisation, which, according to Kmietowicz (2014), needs to stop.  
 
The following chapter will harvest the findings from this study and present concluding remarks, 
confirming that variation is a wide-ranging, long-standing difficult problem to resolve, not only for 
the NHS in England but world-wide, which has implications for practice. 
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Chapter 8: Conclusion and implications for practice 
 
8.1 OVERVIEW 
 
This study set out to investigate the concept of variation in health care, in particular why they are a 
problem, what should be done to identifying and reducing unwarranted variation and what barriers 
there are which prevent the NHS taking action. During this five-year study the review of the 
literature has identified several recurrent themes which shaped the conceptual framework and a line 
of inquiry to answer the research questions (section 1.1). This chapter will now draw those findings 
together to a conclusion and highlight the implications for practice and areas for future research. 
 
The literature revealed that the concept of variation has been a challenge to the NHS in England for 
more than 65 years (Glover, 1938). It remains an unsolved puzzle to date with many articles over the 
decades establishing the prevalence of unwarranted variation (McPherson et al, 1982; Chassin, 
1993; Stukel et al, 2005; Wennberg, 2010).   Whilst ample literature exists to express the problems 
of unwarranted variation, there is a paucity of literature to move the debate forward, beyond the 
observation and recording of variation, to describe what should be done to address the problem 
(DaSilva, 2013). That problem, however, is not an issue for the NHS in England alone; many countries 
are facing the same challenge to understand what barriers prevent the health systems identify and 
reduce unwarranted variation (Corallo et al, 2014).  
 
This offers an authenticity to this study and a justification that is further strengthened by the lack of 
any material to guide readers to appreciate how the NHS perceives the issue, from both the 
commissioning and provider perspective and what the NHS considers are barriers preventing action 
to reduce unwarranted variation. This study has taken up that challenge aiming to create new 
knowledge to nudge that debate forward. 
 
This study has presented fresh and timely insight, confirming that the concept of unwarranted 
variation is fairly well acknowledged but poorly understood, demonstrated by the ample fresh 
evidence that reducing unwarranted variation is an issue that the NHS believes it should address and 
that the majority of staff consider doing so a part of their role. This study has also confirmed that 
little or no action is being taken, by either national or local commissioning organisations or provider 
organisations, with the indication that there is a gap in knowledge which impedes the NHS taking 
action. Mulley (2009) asserts that we need to have both the curiosity and competence to resolve the 
  97 
problem of unwarranted variation but it appears the NHS only meets half of his aspiration (DaSilva, 
2013) it has some curiosity but lacks competence.  
 
The verification from the NHS that tackling variation is important is welcome and suggests a way 
forward, but that declaration hides many of the potential barriers that prevents action being taken 
and why the puzzle of unwarranted variation remains unsolved: the power struggle and lack of 
mutual respect identified between commissioning and provider organisations on which organisation 
should lead this work and further compounded by the disagreement between clinicians and 
managers who should lead this agenda. 
 
One of the significant findings from this study is the marked contrast of views on the topic between 
the two congregations of the NHS - Commissioners and Providers – compounded by a bleak 
discrepancy in the expected behaviours of the national and local commissioning organisations. The 
findings reveal that the national commissioning board have taken no time and put in no effort in to 
understanding the problem of unwarranted variation, but do imply that they expect local 
commissioning organisations – the Clinical Commissioning Groups – to respond to the problem and 
reduce unwarranted variation. Remarkably, the NHS also considers it a role for CCGs but the 
evidence has demonstrated that they have not made much progress, and the evidence suggests that 
action will not be happening any time soon as the CCGs are neglecting to put the topic on their own 
agenda, citing the lack of training as a barrier to taking that action.  
 
The evidence that the topic does not appear on the agenda of CCGs suggests a deeper and more 
troublesome reservation, namely that their agenda may be being set by external, political and 
national, organisations and regulators rather than local organisations aspiring to address the burden 
of disease within their population. This hypothesis is drawn from the claim by Greer et al (2014) that 
gestures to decentralise are often covertly diluted by increasing the powers of central regulators and 
the evidence of the confusion and lack of leadership on this topic from the executive members of 
the NHS Commissioning Board, where there is a level of dissent amongst those members about not 
only whether they should respond but also about what should be done to reduce unwarranted 
variation. This position is a contradiction of the way the executive members behave when it comes 
to other more robust and tangible measures of national targets, a point not lost on the GPs who 
anticipate that NHS management will try to reduce unwarranted variation through a performance 
management route (DaSilva, 2012b). 
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This is an interesting conclusion as the case for local commissioning organisations to take the 
necessary action has no rational explanation, or incentive and is a case built on a loose argument of 
logic alone. That sense of logic is probably constructed from the perception that the commissioning 
organisations receive the majority share of NHS funds from the government to determine local 
services to meet the need of their population. The essence of logic continues that commissioning 
organisations could use some of these funds to invest in resolving the problem of identifying and 
reducing unwarranted variation. However, that comes with some awkward questions obtained from 
the evidence that; first, would the CCGs know where to place that investment; second, what return 
would they expect from that investment; and third, how would they monitor the impact of the 
investment?  
 
Those questions were not lost on some of the respondents who declare that a reason why 
commissioning organisations are failing to act is that the expectation is made all the more difficult 
with the tightening management controls and reducing structures of the local commissioning 
organisations. One profound message from this study has been the impact that the separation of 
public health expertise, moving out of the CCGs and into the arena of the local authority will have on 
the reduction of unwarranted variation.  
 
Another conclusion from this study to explain why the NHS is not taking action to reduce 
unwarranted variation is the powerful resistance from provider organisations who are not only 
overtly hostile to the notion that commissioning organisations doing this work but are adamant that 
it is their role and their role alone. Interestingly, that belief is clearly flawed and their claim 
weakened when it is noted that if provider organisations really do think it is their role, then why 
have they not done much about it for the life-span of the NHS?  The perception of commissioners, by 
providers, is one of very little trust or confidence in the capability of commissioners, which may, of 
course, not be limited to the work on identifying unwarranted variation, but may be a much deeper 
routed problem. 
 
This study has demonstrated that the constant churn and re-organisation of the NHS has also been 
cited as one of the reasons the NHS does not focus on reducing unwarranted variation as there is a 
political/managerial tension of delivering short term objectives. That tension leads to a blockage of 
innovation and progress when managers and professionals clash over the management and 
organisation of services.  
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This study concludes with the knowledge that the NHS is aware that it should reduce unwarranted 
variation in the provision, uptake and costs of health care but acknowledges the problem is not 
going to be addressed any time soon without stronger leadership, better training and a clearer 
articulation of the not only why the NHS should respond, but how and who should respond. 
 Nevertheless, that does not mean that this study has fallen short. On the contrary, the study has 
shed new light on the topic and exposed some of the barriers that prevent the NHS responding to 
the call to reduce unwarranted variation and has offered solutions to assist the NHS deal with this 
important policy issue and will conclude the study with implications for practice. 
 
8.2 IMPLICATIONS FOR PRACTICE 
 
What is clear is that this important piece of health policy has drifted for years and still the NHS 
considers that tackling variation is an issue of importance. It is recommended that both 
commissioning organisations and provider organisations need to work together, and be equally 
involved in the investigation, classification, mitigation and reduction of unwarranted variation, 
supported by the national regulators through a concordat holding each to account. The findings 
from this study confirm that without the political, managerial and professional will and a new sense 
of leadership, with a well-constructed argument to support the claim that the NHS should reduce 
unwarranted variation, nothing will improve and the current position of inertia, where unwarranted 
variation goes unchallenged, will prevail. To move the debate forward, beyond that sense of inertia 
this study has highlighted 5 key steps: 
 
1. A concordat is required between all major national health care organisations. 
2. A national conduit is established to harvest, harness and share knowledge – this could, over the 
longer term, hold the concordat between national organisations assuring that the system levers 
and incentives are aligned. 
3. An urgent improvement in the availability of training on the subject with modules to increase 
awareness and confidence to be able to investigate and address unwarranted variation. 
4. A policy initiative which introduces the requirement of a variation impact assessment when NHS 
organisations are considering making significant reform and reorganisation to NHS services. 
5. A clear process of engagement during reform. 
 
The first two steps were discussed in the previous chapter and based on perceived gap in knowledge 
about how to identify, classify and reduce unwarranted variation. This is verified by the appeal for 
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training and development to be made available as a means of improving this situation. This 
awareness raising should be developed to enhance the confidence and competence of individuals, 
teams and their organisations to understand both the concept of variation and to create new 
opportunities to take action to identify and reduce unwarranted variation. 
 
At present, the NHS in England does not have a focal point; it appears to be left to chance and it is 
proposed that this position can be better co-ordinated and facilitated by the creation of a central 
conduit for the harvesting, harnessing and sharing of the current knowledge. This facility, ‘the 
Variation Knowledge Service’ could be a virtual organisation, sitting alongside the national concordat 
and working across each of the seven organisations to assist in the development of a common 
narrative, definition and development programme. Alternatively, it could be a tangible organisation, 
hosted and located within an established academic organisation with an initial funding stream from 
the seven major organisations through the concordat to work to align incentives and regulations, 
develop training and offer specialist advice and consultancy. 
 
The outcome from these first two suggestions is that the NHS, as a system, creates: 
 
 a rational a cogent argument to explain why the action is important 
 a clearly articulated definition to enable the service to respond 
 an explicit, not implicit, claim that this is the role of the whole NHS, rather than the 
responsibility of just the local commissioning organisations 
 incentives and enablers for the system to function together without penalty 
 measures of success and processes to rapidly disseminate learning 
 
The next step is linked to the first steps and instrumental in raising the profile and action to reduce 
unwarranted variation. The proposal is the development of national policy which would see the 
introduction of a ‘variation impact assessment’ (VIA) as a key component of all reconfigurations and 
reorganisations of NHS services. The ‘VIA’ would be a public document declaring how the 
reconfiguration of a service would lead to, at least no further unwarranted variation in the provision, 
uptake and costs of health care and where possible how it would reduce unwarranted variation. The 
responsibility for undertaking and signing off this assessment would be for the commissioning and 
provider organisations, as a joint process with their Regional officer and Health-watch; the national 
consumer champion in health and care with statutory powers to ensure the voice of the consumer is 
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heard by those who commission, provide and regulate services.  Without this sign off, no significant 
reorganisation or reconfiguration should proceed.  
 
The main aim of this critical piece of work is to assure the public that unwarranted variation will not 
be ignored and that the NHS will continually search for and address that variation, releasing 
resources to go toward higher value health care. Through the introduction of a ‘Variation Impact 
Assessment’ NHS organisations, their clinicians and managers, would work together to seek out and 
understand the level of unwarranted variation in their practice and assure the public that any 
changes to services will not increase the level of unwarranted variation, which causes harm, waste 
and duplication of services (DaSilva, 2012b; 2012c). The challenge to the introduction of a variation 
impact assessment process, however, is the stark evidence from this study that before this could 
become core business, there are training and development needs to address. 
 
8.3 CONSIDERATION FOR FUTURE RESEARCH 
 
This study has answered the research questions and shed new light on the topic of variation in the 
provision, uptake and costs of health care.  The findings are considered valuable in moving the 
debate forward, but there is acknowledgement that further work is required and further research to 
maintain the impetus. It is suggested that one of the key areas for future research could be to 
mitigate some of the limitations of this study and repeat it, taking a longer period of time to seek a 
higher response rate and perhaps breaking down responses to understand if there is any significant 
difference between clinicians and managers, or a difference in perception between those working in 
primary care and those in secondary care. That study could also explore the current availability of 
training including where, if at all, the concept of unwarranted variation can be found as a part of 
core professional training modules. 
 
It is suggested that future research also seeks to explore and understand in more detail each of the 
recurring themes highlighted throughout this study. For example, reform and reorganisation has 
become a key theme from the literature and the findings of this study, as has the separation of 
commissioning and provider organisations, and it would be of benefit to gain a deeper 
understanding of the way reform could contribute to the quest to identify and reduce unwarranted 
variation. A key aim would be to understand whether the processes in place to retain market 
principles and competition increase or reduce unwarranted variation. 
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A further area of research would be to understand the governance arrangements of CCGs and work 
out why this topic is not finding its way onto the governing body agenda. This study has revealed 
that CCGs do not appear to have the issue of unwarranted variation on their agenda. It would be of 
great value to understand why this is the case and what, if anything, may reverse that trend. 
Furthermore, it would be of equal interest to find out whether provider organisations discuss this 
issue at board level, or within their organisational directorates, and whether the topic of 
unwarranted variation gets onto their agenda too, as well as to understand how both commissioning 
and provider organisations arrange their business, in particular, how matters of importance are 
selected and find their way onto the governing body agenda. 
 
Another topic to explore would be how the NHS could incentivise action to identify and reduce 
unwarranted variation. The current payment structures within primary care and secondary care 
differ slightly with a ‘fee for service’ contract in general practice and the ‘payment by results’ 
scheme in secondary care. A powerful piece of research would be to investigate the impact these 
payment systems have on unwarranted variation in the provision, uptake and costs of health care, 
and whether those payment systems increase the perceived tolerance of unwarranted variation and 
whether the payment systems reduce the scope and ambition of commissioners or providers to 
respond to the challenge of identifying and reducing unwarranted variation. 
 
Of equal importance, would be to explore and appreciate the circumstances leading innovation to 
generate variation in the provision, uptake and costs, and how those innovations can be spread and 
disseminated across the NHS as a method of rapid transformation and improvement of care. The 
question here would be to understand why some organisations are doing something about 
transforming services whilst others appear not to. 
 
The first phase of this post-doctoral study will be to investigate the level of acceptance of the 
suggested implications for practice and to identify the potential to pursue these to test them out as 
being sensible and deliverable. Included in this piece of work will be an attempt to understand what 
support mechanisms are in place and what barriers need to be isolated and removed to make them 
happen. Only then might we understand how the NHS, as a system, can collaborate to classify, 
identify, reduce and mitigate unwarranted variation in the provision, uptake and costs of health 
care. That has to be worth exploring! 
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